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 ABSTRACT 
Generalized aggressive periodontitis (GAgP) is a multifactorial disease caused by an unbalance 
between the host response e the biofilm aggression. It is characterized by the familial 
aggregation of cases, probably associated with the sharing of susceptibility aspects between 
family member, what could increase the risk to GAgP descendants to develop GAgP.  In this 
context, the present report describes three different studies: the first aiming to characterize the 
microbiome, as well its association to the host response, in GAgP subjects and their children; 
the second study aiming to evaluate the effective of plaque control in altering the pathogenic 
subgingival condition identified in GAgP descendants; the  third aiming to evaluate the 
efficiency of Triclosan-containing toothpaste as an adjunctive therapy to control the precocious 
alteration demonstrated in GAgP descendants. In the first study, 15 GAgP parents with at least 
a child between 6-12 years old and 15 health parents with at least one child between 6-12 years 
old were selected. The clinical examination and the collection of subgingival biofilm and 
gingival crevicular fluid (GCF) were performed for all subjects. The bacterial DNA of the 
subgingival biofilm was extracted, the 16S rRNA was sequenced using the Illumina MiSeq 
platform and bioinformatic tools were used to analyze the data. The gingival crevicular fluid 
was analyzed with the Luminex MAGPIX technology for the identification of interferon (IFN)-
γ, and tumor necrosis factor (TNF)-α, interleukin (IL)-10, IL-4, IL-1β, IL-17, IL-6, IL-8 levels. 
Children from GAgP parents presented the worst clinical condition as well as a more pathogenic 
and dysbiotic microbiome than children from healthy parents. A strong correlation was 
observed between the parent microbiome and his child microbiome. Differences in the 
cytokines’ levels were only observed in parents with GAgP parent presenting lower levels of 
IFN-γ, IL-10, and IL-17. Despite no differences in the cytokine levels, children from GAgP 
parents presented alteration in the host-bacterial interactions and demonstrated a similar pattern 
to their parents. In the second study, 18 children (6-12 years old) from GAgP parents and 18 
children from periodontally healthy parents were included in a plaque control program for 3 
months. All subjects were periodontally examined and subgingival biofilm and gingival 
crevicular fluid (GCF) were collected at baseline and after 3 months of strict plaque control. 
Next-generation sequencing and bioinformatic tools were used to evaluate the subgingival 
microbiome and the Luminex/MAGPIX platform was used for the inflammatory analysis in 
GCF. The Linear Discriminant Analysis of Morisita-Horn index demonstrated two massive 
clusters separating children from AgP parents from children from healthy parents (Adonis test, 
p=0.014), demonstrating a significant impact of parental periodontitis on the microbiome of 
their descendants. A more pathogenic microbiome associated with more intense host-bacterial 
interactions and worst clinical condition was identified in children from GAgP parents. The 
dysbiotic microbiome of GAgP descendants showed a strong resilience against shifting after 
 plaque control, maintaining the diversity and the richness of disease-associated species even 
after the clinical benefits achieved. In addition, plaque control was not sufficient to alter the 
pattern of host-bacterial interaction in the subgingival environment. In the third study, 15 
children from GAgP parents and 15 children from periodontally healthy parents were included 
in this cross-over placebo study. Children were randomly allocated into Triclosan or Placebo 
groups to participate in the first phase of the study. Initially, all children participate in a wash-
out period of 15 days using only the placebo toothpaste and posteriorly they started to use the 
elected toothpaste for 45 days. After the first phase, they repeated the period of 15 days of wash-
out using only the placebo toothpaste. The groups were crossed, and the children used the other 
paste for more 45 days. In each phase, clinical examination and saliva, GCF and subgingival 
biofilm collection were performed at baseline and 45 days. The levels of IFN-γ, IL-4, IL-10, 
IL-1β, IL-17, and TNF-α were analyzed by Luminex/MAGpix platform and subgingival and 
salivary periodontal pathogens’ levels by qPCR. At baseline, children from AgP parents 
presented higher levels of the gingival index (GI), plaque index (PI), and bleeding on probing 
(BoP), a higher concentration of Aggregatibacter actinomycetemcomitans (Aa) in saliva and 
subgingival biofilm, and lower levels of INF-ɣ, IL-4, IL-17 in the GCF. Placebo therapy only 
reduced PI, in both groups. Triclosan toothpaste reduced PI, as well as GI, in both groups. 
Moreover, Triclosan promoted the reduction of BoP and PPD, Aa salivary levels and IL-1β in 
GAgP group. In Health group, Triclosan promoted a reduction of INF-ɣ and IL-4. In conclusion, 
the microbiome and the host-bacterial interaction were altered in GAgP parent and their 
descendants and a strong impact of the parents’ periodontal condition in their children 
periodontal status was demonstrated. The dysbiosis was associated with more intense species 
cytokines correlations and higher clinical inflammation. The plaque control was not able to 
change the more pathogenic subgingival environment of GAgP descendants, that demonstrated 
a strong resilience to subgingival microbial shifting after strict plaque control, highlighting the 
higher risk for disease development. Furthermore, Triclosan dentifrice demonstrated to be more 
efficient than placebo toothpaste to control the more pathogenic profile demonstrate in GAgP, 
by reducing the bleeding on probing, probing depth, salivary Aa and IL-1β, in children from 
GAgP parents. 
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 RESUMO 
Periodontite agressiva generalizada (PAG) é uma doença multifatorial causado por um 
desequilíbrio entre a resposta do hospedeiro e as agressões do biofilme. Ela é caracterizada pela 
agregação familiar dos casos, provavelmente associada ao compartilhamento de fatores de 
susceptibilidade entre membros de uma mesma família, o que poderia aumentar o risco de 
descendentes de indivíduos PAG também desenvolverem a doença. Neste contexto, o presente 
trabalho descreve três estudos diferentes, um com o objetivo de caracterizar o microbioma, 
assim como a sua associação com a resposta do hospedeiro, em indivíduos PAG  e seus filhos 
e o segundo estudo objetivando avaliar a pasta de dente contendo Triclosan como uma terapia 
adjunta no controle das alterações precoces demonstradas em descendentes PAG. No primeiro 
estudo 15 pais PAG com pelo menos um filho com idade entre 6 e 12 anos e 15 pais 
periodontalmente saudáveis com pelo menos uma criança entre 6 e 12 anos foram selecionadas. 
O exame clínico e a coleta de biofilme subgengival e fluido gengival (GCF) foram realizados 
para todos os participantes. O DNA bacteriano do biofilme subgengival foi extraído, a região 
16S do rRNA foi sequenciado utilizando a plataforma Illumina MiSeq e ferramentas de 
bioinformática foram utilizadas para analisar os dados. O fluido crevicular gengival foi 
analisado com a tecnologia Luminex MAGPIX para a identificação das citocinas interferon 
(IFN) -γ, fator de necrose tumoral (TNF-α) e interleucinas (IL) -10, IL-17, IL-1β, IL-4, IL-6, 
IL-8. Crianças de pais PAG apresentaram piores condições clínicas, bem como um microbioma 
mais patogênico do que crianças de pais saudáveis. Uma forte correlação foi observada entre o 
microbioma do pai e o microbioma de seu filho. Diferenças nos níveis de citocinas foram 
observadas apenas em pais PAG que apresentaram níveis menores de IFN-γ, IL-10 e IL-17. 
Apesar de não haver diferenças nos níveis de citocinas, as crianças dos pais PAG apresentaram 
alteração nas interações entre bactérias e o hospedeiro e demonstraram um padrão similar ao 
apresentado por seus pais. No segundo estudo, 18 crianças (entre 6 e 12 anos) filhas de 
indivíduos PAG e 18 criança filhas de ambos os pais periodontalmente saudáveis foram 
incluídas em um programa de controle de placa por 3 meses. Todos os indivíduos foram 
periodontalmente avaliados e submetidos a coleta de biofilme subgengival e GCF no início do 
estudo e após 3 meses de controle de placa. Sequenciamento de nova geração e ferramentas de 
bioinformática foram utilizadas para a avaliação do biofilme subgengival enquanto a plataforma 
Luminex/MAGPIX foi usada para aas análises inflamatórias no GCF. Análise de discriminantes 
lineares do índice Morisita-Horn demonstrou dois aglomerados maciços separando filhos de 
pais PAG de filhos de pais saudáveis (teste Adonis, p=0.014), demonstrando um impacto 
significativo da doença periodontal parental no microbioma de dos seus descendentes. Um 
microbioma mais patogênico associado com maior interrelação bactéria-hospedeiro e piores 
condições clínicas foram identificadas em crianças PAG. O microbioma disbiótico de 
 descendentes PAG mostrou uma forte resiliência a mudança depois do controle de placa, 
mantendo a diversidade e a riqueza de espécies associadas a doença periodontal mesmo depois 
que benefícios clínicos forma atingidos. Além disso, o controle de placa não foi suficiente para 
alterar o padrão de interações entre o microbioma e o hospedeiro. No terceiro estudo, 15 
crianças de pais PAG e 15 crianças de pais periodontalmente saudáveis foram incluídas neste 
estudo placebo cruzado. As crianças foram alocadas aleatoriamente nos grupos Triclosan ou 
Placebo para participar da primeira fase do estudo. Inicialmente, todas as crianças participaram 
de um período de wash-out de 15 dias usando apenas o creme dental placebo para 
posteriormente começaram a usar o creme dental selecionado por 45 dias. Após a primeira fase, 
eles repetiram o período de 15 dias de wash-out usando apenas o creme dental placebo. Os 
grupos foram cruzados e as crianças usaram a outra pasta por mais 45 dias. Em cada fase, foram 
realizados exame clínico e coleta de saliva, GCF e biofilme subgengival no exame inicial e aos 
45 dias de estudo. Os níveis de IFN-γ, IL-17, IL-4, IL-1β, IL-10 e TNF-α foram analisados pela 
plataforma Luminex / MAGpix e os níveis de patógenos periodontais salivares e subgengivais 
por qPCR. No início do estudo, as crianças dos pais PAG apresentaram maiores índice de placa 
(IP), índice gengival (IG) e sangramento à sondagem (SS), além de maiores concentrações de 
Aggregatibacter actinomycetemcomitans (Aa) na saliva e no biofilme subgengival e menores 
níveis de INF-ɣ, IL-4, IL-17 no GCF. A terapia com placebo apenas reduziu o IP, em ambos os 
grupos. O creme dental com Triclosan reduziu o IP, assim como o IG, em ambos os grupos. 
Além disso, o Triclosan promoveu redução adicional do SS, da profundidade de sondagem 
(PS), dos níveis salivares Aa e IL-1β no grupo PAG. No grupo de saúde, Triclosan promoveu 
uma redução de INF-ɣ e IL-4. Em conclusão, o microbioma e as interações hospedeiro-biofilme 
foram alterados nos indivíduos PAG e seus descendentes e uma forte correlação entre o estado 
periodontal dos pais e de seus filhos foi demonstrada. A disbiose foi relaciona com correlações 
mais intensas entre as bactérias e o hospedeiro e maior inflamação clínica. O controle de placa 
não foi suficiente para mudar o ambiente subgengival mais patogênico em descendentes PAG, 
que demonstrou uma alta resiliência para as mudanças microbiológicas e destacou o maior risco 
para o desenvolvimento de doença periodontal. Além disso, o creme dental com Triclosan 
demonstrou-se mais eficiente do que o creme dental placebo em controlar o perfil mais 
patogênico observado em PAG, uma vez que reduziu os níveis de sangramento a sondagem, 
sondagem periodontal, Aa salivar e IL-1β, em crianças de pais PAG. 
 
Palavras-chave: periodontite agressiva, família, suscetibilidade a doença, microbiota, 
inflamação 
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1 INTRODUCTION 
 Generalized aggressive periodontitis (GAgP) is a multifactorial disease that causes rapid 
and severe destruction of the periodontal tissue and affects young and systemic health subjects 
(Armitage 1999). Despite its low prevalence in the worldwide population (Susin et al., 2014), 
GAgP can cause severe periodontal loss, and tooth loss when not treated, a situation that can 
interfere directly in the functional, aesthetic and socioeconomic condition of the affected 
subjects. The major etiological factor of GAgP is the subgingival biofilm that can trigger the 
local inflammatory response and promote the periodontal tissue loss (Kinane et al., 2017). 
Previously, some specific microorganisms, such as A. actinomycetemcomitans (Aa) and the red 
complex (P. gingivalis, T. denticola, and T. forsythia) (Socransky et al., 1998), were suggested 
as etiological agents of periodontitis (Casarin et al., 2010; Haubek, 2010; Nibali et al., 2012) 
and intense investigations were performed trying to identify a specific microorganisms as the 
main cause of periodontal destruction. Many studies, for example, pointed the Aa (more 
specifically the JP2 clone) as the main etiological factor for Aggressive periodontitis and as a 
potential risk factor for future attachment loss in adolescents (Haubek, 2010; Shaddox et al., 
2012; Fine et al., 2013; Höglund Åberg et al., 2014). However, many studies do not confirm 
this association and no consensus was obtained about their role in periodontitis.  
The new technologies for microbial evaluation, such as the non-culture techniques and 
the DNA sequencing, allowed a broad interpretation of the biofilm that colonizes the 
subgingival environment and the identification of new microorganisms with potential 
involvement in the periodontitis initiation and progression (Hajishengallis and Lamont 2012). 
Thus, a holistic view of the subgingival community was possible, favoring the understanding 
of a multifactorial and complex disease as periodontitis. The current comprehension of 
periodontal disease describes that the dysbiosis (a change in the relative abundances of 
individual components of the microbiota compared with their abundance in health) in 
subgingival environment is related to an unbalance between the host response and the microbial 
aggression which can cause the periodontal breakdown (Hajishengallis et al., 2012; Könönen 
and Müller, 2014; Lamont et al., 2018). Thus, alterations on the whole microbiome, and not in 
some specific species, were essential for creating a pathogenic community able to promote 
destruction. In this context, some microorganisms were described as essential to the modulation 
of the whole community. The P. gingivalis was suggested as a keystone pathogen, a species 
that even in low abundance has a large effect and importance in the community’s structure 
(Hajishengallis et al., 2012). This microorganism would have the ability to impair the host 
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response and to modulate functionally the whole community, giving the environmental 
conditions and supporting the overgrowth of commensal microorganisms, that under specific 
conditions have the ability to disrupt the host homeostasis (pathobionts), and producing 
dysbiosis (Hajishengallis et al., 2012).  
Despite the importance of the microbial component in the periodontitis pathogenesis, 
the host-related factors have an essential role in the initiation of periodontal destruction 
(Kulkarni and Kinane, 2014; Vieira and Albandar, 2014). It is suggested that genetic alterations 
that modulate the host response are involved on GAgP pathogenesis and that the quality of the 
inflammatory response should be essential to determine the disease occurrence and severity 
(Shaddox et al., 2010; Vieira and Albandar, 2014). Some studies have demonstrated how the 
genetics can promote a selective pressure in the microbiome and influence the abundance of 
some specific microorganism (Nibali et al., 2007; Nibali et al., 2009; Eskan et al., 2012; Cavalla 
et al., 2018). Thus, by altering some specific colonization factors or by altering the host 
response/the inflammatory pattern locally, the host could produce the ecologic conditions 
necessary for the outgrowth of specific bacteria and the dysbiosis occurrence (Hajishengallis, 
2014; Lamont et al., 2018). In fact, inflammation and dysbiosis are important to sustain each 
other and positively reinforce the disease cycle, once dysbiosis stimulates the inflammatory 
response at the same time that inflammation creates the environmental conditions to support 
the growth of some “inflammophilic” bacteria and stabilizes the dysbiotic associated microbiota 
(Lamont et al., 2018).  
 One of the most important characteristics of GAgP is the familial aggregation and the 
accumulation of cases in the same family turns around 40 to 50% (Michalowicz et al., 2000; 
Meng et al., 2011). It is attributed to the sharing of risk factors within family members, such as 
genetic aspects, an altered inflammatory response, the bacterial transmission and the sharing of 
environmental and behavioral conditions, increasing their susceptibility to also develop the 
disease (Haubek, 2010). In this context, our research group started to evaluate descendants of 
GAgP subjects, focusing in understand the aspects associated with susceptibility to disease and 
many alterations were described even before the clinical sign of disease. Monteiro et al (2014), 
described higher colonization for Aa in the saliva of children from GAgP parents when 
compared to children from healthy parents and the fact of a parent be colonized by Aa increases 
in 16 times the chance of a child to be colonized by this microorganism. Posteriorly, it was 
demonstrated that children from GAgP parents presented the worst clinical conditions, higher 
colonization by Aa in the subgingival environment and the higher levels of Aa were directly 
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correlated to gingival bleeding (Monteiro et al., 2015). These studies highlight that initial 
changes were presented in GAgP descendants, and that they could be the initial sign of disease 
or could represent a risk to this population that should be clinically monitored and the focus on 
more investigations.  
 The study design of families, analyzing descendants of GAgP, demonstrated to be 
effective in identifying alterations, what could help the comprehension of pathogenic aspects 
still not completely understood and the identification of risk markers and alterations previously 
to periodontal destruction. However, the comprehension of the complex and dysbiotic 
microbiome that characterize GAgP, and its interplay with the host response, requires the use 
of more robust technologies and the joint analysis of microbiological and inflammatory aspects 
involved in the periodontal breakdown. Thus, a new study was necessary to characterize the 
subgingival environment of GAgP, as well as to understand the impact of the parent periodontal 
condition on the periodontal status of their offspring, investigating the possible aspects related 
to the familial component and the susceptibility to periodontitis. Moreover, once the precocious 
alterations were identified, clinical procedures were tested as an option to the treatment and the 
preventive management of this risk population.  
The plaque control is the first option to control oral conditions associated with plaque 
accumulation, especially in a vulnerable group as children. It is a non-invasive therapy and it 
has demonstrated efficacy in controlling the clinical inflammation (Löe et al., 1965; Trombelli 
et al., 2004) and that way the risk for periodontal destruction in a long-term (Lang et al., 2009). 
Thus, this approach should be tested as the initial option to modulate the pathogenic-associated 
subgingival condition and risk.  Additionally, the use of chemical agents in association with 
plaque control is an interesting choice to increase the potential of plaque removal to modulate 
the subgingival environmental conditions. The triclosan is an antimicrobial and anti-
inflammatory component commercially available in toothpaste (Riley and Lamont, 2013). 
Clinical studies have demonstrated the potential of Triclosan-containing toothpaste to improve 
the periodontal parameters (Panagakos et al., 2005; Ribeiro et al., 2018), to reduce pathogens 
levels, such as Aa and P. gingivalis (Pancer et al., 2016), and to modulate the inflammatory 
response in vitro and in vivo (Barros et al., 2010; Pancer et al., 2016; Ribeiro et al., 2018). 
Moreover, the toothpaste with Triclosan is an easy-to-use and secure form of application and it 
would represent no substantial change in children hygiene habits, facilitating the accessibility 
and compliance.  
18 
 
Thus, three studies were proposed. The first study aimed to evaluate the microbiome, as 
well its relationship with the host response, in GAgP subjects and their children compared to 
healthy subjects and their children. The second study aimed to evaluate plaque control as a 
therapeutic and preventive approach to modulate the clinical and subgingival pathogenic 
alterations in the GAgP descendants. Finally, the third study aimed to test the efficiency of 
Triclosan-containing toothpaste as adjunctive therapy to plaque control in children from GAgP 
parents.  
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ABSTRACT 
Aggressive Periodontitis (AgP) is a multifactorial disease caused by an unbalance between the host 
response and the bacterial challenge and the transmission of characteristics from an affected subject to 
their descendants is supposed to be related to disease susceptibility. Thus, this study aimed to evaluate 
the clinical, microbiological and inflammatory pattern of AgP parents and their children compared to 
healthy families. Fifteen AgP and 15 healthy families with children between 6-12 years old were selected 
and clinical evaluation and samples collection was performed. The bacterial DNA of the subgingival 
biofilm was extracted, the 16S rRNA was sequenced using the Illumina MiSeq platform and 
bioinformatic tools were used to analyze the data. The gingival crevicular fluid was analyzed with the 
Luminex MAGPIX technology for the identification of cytokine levels. Children from AgP parents 
presented the worst clinical condition as well a more pathogenic microbiome than children from healthy 
parents. A strong correlation was observed between the parent microbiome and his child microbiome. 
Differences in the cytokines levels were only observed in parents with AgP parent presenting lower 
levels of interleukin (IL)-10, IL-17 and interferon-ɣ. Despite no differences in the cytokine levels, 
children from AgP parents presented alteration in the host-bacterial interactions and demonstrated a 
similar pattern to their parents. In conclusion, the microbiome and the host-bacterial interaction were 
altered in AgP parent and their descendants and a strong correlation between the parent and his child 
periodontal status was demonstrated, which should be related to disease pathogenesis and to 
susceptibility to AgP. 
 
Keywords: periodontitis, family, microbiome, dysbiosis, inflammation 
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INTRODUCTION 
Understanding periodontal disease is a challenging task because of its multifactorial nature. The 
periodontal environment is colonized by a polymicrobial and complex biofilm that, in a health condition, 
is balanced with the immune system (Kinane, Stathopoulou, and Papapanou 2017). However, it is 
suggested that once a dysbiotic biofilm is established on the subgingival area, the way the immune 
system deal with the local aggression changes, creating an unbalance in the host-bacterial interactions ( 
Hajishengallis and Lamont 2012). Despite all the efforts to identify the major factors associated to its 
pathogenesis, it is still unclear the real impact of specific pathogens or the whole microbiome and the 
host inflammatory response triggering the lesions on the periodontal tissue (Könönen and Müller 2014; 
Vieira and Albandar 2014).  
 Most studies focus on investigating the microbial and the inflammatory components of 
periodontitis separately, ignoring the clear association between the two aspects. Furthermore, they 
generally evaluate both conditions when the disease already exists, identifying the disease aspects, such 
as the microbiome composition or a hyperinflammatory condition, instead of the determinant events 
prior to disease occurrence. Thus, evaluating diseased subjects can be important to understand the 
diseased environment, while the evaluation of a risk population to develop disease allow the  
identification of precocious alterations and pathogenic events associated with a periodontal breakdown.  
 In this context, our research group used the idea of familial aggregation of Aggressive 
Periodontitis (AgP), one of the most important characteristics of the most severe case of periodontal 
destruction (Armitage 1999), to search for a risk population for periodontitis development and to 
understand the events associated to periodontitis etiology and its initiation. The study design of families 
with a history of AgP was used previously (Monteiro et al. 2014, 2015), and it was demonstrated that 
initial alterations can be identified in early ages and even before any clinical sign of disease. Higher 
frequency of detection and concentration of A. actinomycetemcomitans (consider an important 
periodontal pathogen of aggressive forms of periodontitis) in saliva and high risk of colonization by 
these bacteria in children from AgP families were observed (Monteiro et al. 2014). In addition, high 
colonization by this pathogen on the subgingival biofilm, and higher levels of bleeding and probing 
depth were demonstrated on children from AgP families which could represent initial alterations 
previously to disease diagnose (Monteiro et al. 2015). Despite these differences, these previous studies 
focused on some specific microorganisms, suggested as important periodontal pathogens, to understand 
the familial component and risk to AgP. Meanwhile, the emerging evidence points to the importance of 
the whole microbiome, a dysbiotic community and an unbalance in the host response in disease 
pathogenesis. Therefore, it is still necessary a more extensive characterization of this risk population by 
investigating the composition of  the whole microbiome and the periodontal inflammatory condition of 
AgP descendants, as well as the impact of the parents periodontal status on their children periodontal 
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status, focusing mainly in identifying risk factors associated to disease occurrence, to understand the 
etiological components associated with the periodontal breakdown and to identify who is the susceptible 
group to periodontitis.  
Thus, the goals of this study were to evaluate the microbiome, the inflammatory pattern, as well 
the relationship between them, on parents with a history of AgP and their children compared to healthy 
individuals and their children.  
 
MATERIALS AND METHODS 
 The study was conducted at Piracicaba Dental School, University of Campinas, Brazil and was 
approved by the local Ethical Committee, process 079/2013. The study was designed as an age- and 
gender-matched, case-control trial to assess the clinical, microbiological and inflammatory 
characteristics of subjects with a history of AgP and their children. 
 Thirty families were selected and divided into two groups:  
- AgP group (n=15): families in which the parents (or at least one of them) present generalized 
aggressive periodontitis and at least one child (age ranging from 6–12 years old);  
- Health group (n=15):  families in which the parents (both of them) present periodontal health and one 
child (age ranging from 6–12 years old). 
 The inclusion criteria were:   
- AgP parents (since the study begun in 2014, AgP diagnosis was based on AAP 1999 classification 
(Armitage 1999)) i) less than 35 years old at the diagnosis; ii) at least 8 teeth with probing depth (PD) 
and clinical attachment level (CAL) > 5mm (with at least 2 sites with PD > 7mm) at diagnosis; iii) at 
least 20 teeth in the oral cavity; iv) good systemic health (Taiete et al. 2017).  
- Health parents: i) Good systemic health; ii) at least 20 teeth in the oral cavity; iii) absence of periodontal 
pockets/gingival sulcus with PD > 4mm; iv) absence of proximal bone loss (Taiete et al. 2017).  
- Children: i) to present parents respecting the inclusion criteria for periodontal health or AgP; ii) 6 to 
12 years of age at the beginning of the study iii) good systemic health iv) presence of first molars and 
central incisors.  
 The exclusion criteria for all subjects were: i) the use of antibiotics and anti-inflammatory 
medication 6 months prior to the study; ii) smoking habits iii) pregnancy or lactation.  
 All subjects were clinically assessed by a calibrated examiner (MFM - Intra-class 
correlation=92% of PD). The clinical parameters evaluated were the following: plaque index – PI 
(Ainamo and Bay 1975), gingival index – GI (Ainamo and Bay 1975), probing depth – PD (distance of 
23 
 
gingival margin to bottom of periodontal pocket/sulcus), clinical attachment level – CAL (distance from 
the cementoenamel junction to the bottom of periodontal pocket/sulcus), bleeding on probing – BoP 
(Mühlemann and Son 1971). 
Microbiome analysis 
 Subgingival biofilm was collected from 2 permanent incisors and 2 permanent molars of 
children and their parent by the examiner (MFM) at the deepest site of each teeth. Following 
supragingival biofilm removal and relative isolation with cotton rolls, a sterile paper point (Nº35) was 
inserted into the bottom of the periodontal pocket/gingival sulci for 30s. The paper points were placed 
into sterile tubes containing 300 μL of Tris-EDTA 0.5mM and reserved in -20C until laboratory 
evaluation. 
Plaque samples were removed from the paper points by adding 200 ml of phosphate buffered 
saline (PBS) and vortexed for 1 min. The paper points were removed, and DNA isolated using a Qiagen 
MiniAmp kit (Valencia, CA) according to the manufacturer’s instructions. 
The regions V1-V3 and V4-V5 of the 16S rRNA genes were sequenced. The library generation 
was done using an Illumina TruSeq DNA sample preparation kit according to the manufacturer’s 
instructions. Genomic DNA was enzymatically sheared yielding an average fragment size of 500 base 
pairs. The fragment ends were blunted and adenylated, before ligation of barcodes and sequencing 
adaptors. The adaptor-ligated sequences were enriched with 10 cycles of PCR with included Illumina 
primers before the libraries are quantified and pooled. Pooled libraries were clustered on the MiSeq, and 
300bp paired-end sequencing was performed according to the manufacturer’s protocols. The Illumina 
base-calling pipeline was used to process the raw fluorescence images and call sequences. Raw reads 
with >10% unknown nucleotides or with >50% low-quality nucleotides (quality value <20) was 
discarded.  
Processing pipeline:  
Analyses were conducted using the QIIME (Caporaso et al. 2010) and PhyloToAST (Dabdoub 
et al. 2016). Sequences with an average quality score of 30 over a sliding window of 50bp and length 
>200 bp were assigned a taxonomic identity by alignment to the HOMD database (Chen et al. 2010) 
using the Blastn algorithm at 99% identity. The chao1 method was used as estimators of alpha diversity, 
and differences between alpha diversities group-wise were measured using the Kruskal-Wallis test. The 
Morisita-Horn dissimilarity distance matrices were used to estimate beta diversity. Linear Discriminant 
Analysis (LDA) was performed on distance matrices, and significance of clustering was interrogated 
using Adonis with 999 permutations. LDA plot and confidence ellipses were generated by the R package 
ggplot. Core species were identified using Qime’s script (core_microbiome.py) when species were 
present in at least 75% of the patients in each group. The Bioconductor package for R, DESeq2, was 
used to perform differential expression analysis of the annotated taxa (Love, Huber, and Anders 2014). 
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This function uses a negative binomial distribution of raw counts to estimate between-group differences 
while accounting for sampling effort (library size) and dispersion of each category (taxon or functional 
gene). p-values were adjusted for multiple testing (FDR < 0.1, FDR-adjusted Wald Test). The similarity 
between the parent and his child microbiome were analyzed using the software EstimateS 9.1.0 
(http://purl.oclc.org/estimates) to estimate the number of shared species and the β-diversity similarity 
between a parent and his child and the SourceTracker 0.9.5 software with QIIME to predict the source 
of child microbial community. The bacterial network correlations were determined by significant 
pairwise using SparCC pipeline (p<0.01, r>0.75) (Pylro et al. 2014) and network graphs were calculated 
in Python (Networkx package) and visualized in Gephi (Bastian, Heymann, and Jacomy 2009).  
Cytokine profile assessment using multiplexed bead immunoassay (Luminex) 
Gingival crevicular fluid (GCF) was collected from the same sites, after at least 30s of biofilm 
collection. The area was isolated, dried and GCF was collected using filter paper strips (Periopaper, 
Oraflow, Plainview, NY, USA) into the subgingival area for 15s. The fluid volume was measured with 
a calibrated device (Periotron 8000, Oraflow, Plainview, NY, USA). The strips were placed into sterile 
tubes containing 100 μL of phosphate-buffered saline (PBS) with 0.05% Tween-20. GCF samples were 
immediately stored at -20°C until multiplexed using a bead immunoassay assay. Cytokine levels of 
interferon (IFN)-γ, interleukin (IL)-17, IL-10, IL-1β, IL-8, IL-4, IL-6 and tumor necrosis factor (TNF)-
α in GCF were determined using the Sensitivity Human Cytokine 08-plex (Millipore Corporation, 
Billerica, MA). Assays were carried out according to the manufacturer’s recommendations using the 
MAGpix™ instrument (MiraiBio, Alameda, CA). The samples were collected as a pool and 
concentrations were estimated from the standard curve using a five-parameter polynomial equation 
using Xponent® software (Millipore, Corporation, Billerica, MA). The mean concentration of each 
marker was calculated using the individual as a statistical unit and expressed as pg/ml. The cytokine 
concentration was correlated with the bacterial abundance to analyze the bacterial-cytokine network. 
The significant pairwise of Spearman’s correlation (p<0.05) was calculated and the network graphs were 
visualized with Gephi software. 
Data analysis 
 For the statistical analysis, the gender distribution was measured by the Chi-Square test while 
the Student’s t-test was used for age. The differences between groups in the clinical parameters were 
evaluated using the Mann-Whitney test due to the non-normal distribution. The inflammatory data were 
normalized using the log transformation and the Shapiro-Wilk test was used to test the normality. As 
the normal distribution was obtained, the Student’s t-test was used to test the differences between the 
Health and AgP groups in parents and children. All tests considered alpha=5%. 
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RESULTS 
 The demographic and clinical data for both groups are observed in table 1. No differences were 
observed regarding the groups’ demographic conditions, demonstrating the aged- and gender-matched 
design of this study. The AgP parents demonstrated a higher level of PD, CAL, and BoP when compared 
to health parents (p>0.05). Children from AgP parents, similarly to their parents, presented worse 
clinical conditions with higher PD and BoP than children from health parents (p>0.05). 
 Table 1. Demographic and clinical data for parents and children  
 
Parent Children 
 
AgP (n=15) Health (n=15) AgP (n=18) Health (n=18) 
Age (years±SD) 36.5±4.32 36.46±3.81 9.7±2.16 9.55±1.97 
Gender (n female) 12 12 8 8 
PI (%±SD) 34.2±14.1 38.5±16.9 55.7±13.9 50.6±22.1 
GI (%±SD) 8.9±2.0 10.5±2.6 24.8±13.2 20±12.1 
PD (mm±SD) 4.3±0.6 3.0±0.5 * 3.5±0.47 3.2±0.30* 
BoP (%±SD) 35.9±11.7 25.5±12.3 * 37.3±14.4 25.8±12.1 * 
CAL (mm±SD) 5.19±1.0 3.0±0.5 * - - 
* Represents differences between AgP and Health (p<0.05, Mann-Whitney test). SD – Standard deviation; PI – Plaque Index; 
GI – Gingival Index; PD – Probing Depth; BoP – Bleeding on Probing; CAL – Clinical Attachment Level 
 The cytokines concentration on the GCF for parents and their children for both groups is 
demonstrated in table 2. AgP presented lower levels of IL-10, IFN-ɣ, and IL-17 than health parents 
(p<0.05). In children, however, no differences were observed in the cytokine levels when the groups 
were compared (p>0.05).  
Table 2. Concentration (pg/mL±SD) of cytokines in the GCF in parents and children for both groups. 
 
Parent Children 
AgP (n=14) Health (n=15) AgP (n=18) Health (n=18) 
IFN-y  14.37±14.81 27.91±21.55 * 15.75±16.64 17.16±21.9 
IL-10 28.02±21.81 41.28±24.32 * 23.6±23.08 18.43±15.55 
IL-17 8.92±7.34 17.33±13.53 * 8.07±7.08 8.65±9.51 
IL-1β 49.65±47.9 52.94±32.99 28.46±47.39 11.35±10.59 
IL-4 19.09±16.43 23.16±13.98 17.91±17.15 13.16±10.61 
IL-6 20.37±15.67 30.44±24.45 19.41±26.03 11.13±9.65 
IL-8 1987.71±1313.27 2069.5±1489.38 805.29±556.43 814.87±575.12 
TNF-α 20.12±15.17 23.02±15.33 14.45±12.29 10.62±8.08 
* Represents differences between AgP and Health (p<0.05, Student’s t-test). SD – Standard deviation; IFN - Interferon; IL – 
Interleukin; TNF - Tumor necrosis factor. 
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Figure 1 demonstrated the differences in the microbiome of subgingival biofilm between 
groups. Figure 1A represents the LDA of Morisita-Horn dissimilarity index. Two clusters were 
observed, one composed by the AgP parents and their children and a second one by the healthy parents 
and their children. No statistical difference was demonstrated between the AgP parent and their children 
(Adonis, p=0.695) and between the health parent and their children (Adonis, p=0.998), while statistical 
differences were demonstrated between AgP and healthy parents (Adonis, p=0.019) and between AgP 
and healthy children (Adonis, p=0.01). The Alpha diversity is shown in figure 1B. Children from AgP 
group presented a higher α-diversity than children from the healthy group (Mann-Whitney test, p=0.02) 
and no differences were observed between parents (Mann-Whitney test, p>0.05). In 1C, D, E, F the 
Deseq2 analysis have shown the bacteria differentially abundant between groups. There were 
demonstrated on the graphs the fold-change between groups only for differences with the p adjusted 
value of 0.05. Interestingly, the differences between aggressive and health groups, both for parent and 
children, were higher than the differences between parents and children from the same group. This 
suggests a high influence of the parent periodontal microbiome on the composition of their children 
microbiome, and the occurrence of precocious alterations in the diversity and the abundance of some 
bacteria in children from AgP parents when compared to children from healthy parents. Thus, the AgP 
parents are influencing the colonization by a microbiome compatible with the disease in their offspring 
since the childhood. 
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Figure 1 Differences in microbial diversity. A) β-diversity, LDA of Morisita-Horn Dissimilarity Index. B) α-diversity, Chao1 estimator. C) Bacteria differentially abundant between AgP and 
health groups in parents. The red bars represent the bacteria increased in AgP parents and the dark green bars the bacteria increased in healthy parents. D) Bacteria differentially abundant between 
AgP and health groups in children. The pink bars represent the bacteria increased in children from AgP parents and the light green bars the bacteria increased in children from healthy parents. E) 
Bacteria differentially abundant between parent and children in AgP group. F) Bacteria differentially abundant between parent and children in the health group.
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  The similarities between the parent and their child are in figure 2. The core microbiome of all 
groups is represented in 2A. A more abundant core is observed for AgP parents and their children, 
suggesting that in the AgP condition a more homogeneous microbiome is observed between the subjects. 
Furthermore, a similarity of the core between parent and children from the same group highlights a great 
similarity within family members and the influence of the parental oral microbiome on their offspring. 
Bacteria such as Filifactor alocis, S. parasanguinis, F. nucleatum, and Selenomonas genera were 
exclusive of the AgP core, while P.gingivalis were exclusive for AgP children and T. forsythia was 
exclusive for AgP parents, demonstrating that some periodontitis-related bacteria were highly prevalent 
in the AgP group and could be related to disease pathogenesis. The figure 2B represents the percentage 
of the child species that were shared with their related parent. A higher influence of the parent microbiota 
is demonstrated in AgP group where 82% of the species of a child from AgP families is shared with his 
parent while approximately 70% of shared species is observed in children from health group (p<0.003). 
The β-diversity similarity between a parent and his child was measured using the Morisita-Horn 
similarity index (figure 2C) and it reveals that the similarity between a parent and his child is higher 
than the similarity between a parent and a non-related child (p=0.0002). In addition, the Source Tracker 
analysis (figure 2D) revealed approximately 50% of the entire microbiome of a child comes from the 
analyzed parent, with no differences between groups, and that the similarity between parents and their 
children microbiome is greater than the similarity between a child and a non-related adult (p=0.0001).  
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Figure 2. The similarity between parents and children microbiome. A) Core microbiome, represent species that were present 
in 75% of the subjects of a group. B) Represent the percentage of species of a child from AgP and health groups that were 
shared with his related parent. C) Represents the similarity in the β-diversity between pairs of a parent and his child and a 
parent and a non-related child. D) Demonstrate the Source Tracker results of the prediction of the child community that comes 
from his parent or from a non-related parent.  
31 
 
Besides the composition of the biofilm, the study evaluates the correlations observed in the 
subgingival environment. The network analysis was used to understand the relationship between the 
species in the microbiome and between the microbiome and the inflammatory cytokines, as 
demonstrated in figure 3. In 3A-D the correlation between bacteria in the subgingival biofilm was 
demonstrated. The healthy parents presented a higher complexity of species correlations than AgP 
parents and the same pattern is also observed for children, with children from health parents presenting 
more complex correlation than children from aggressive parents. Interestingly, an opposite trend was 
demonstrated in the networking between the cytokine’s concentration and the species abundance, where 
a higher complexity of correlations was observed in the AgP group that presents the double of cytokine-
species correlations than the health group. (figure 3E-H). For health parents and their children, fewer 
correlations were demonstrated between species and cytokines, what could suggest low levels of 
aggression on the subgingival environment and equilibrium on the host response. For the AgP group, 
on the other hand, intense host-bacterial interactions were demonstrated, suggesting an intense 
stimulation of the immune system by the microbiome and an unbalance on the cytokine release. 
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Figure 3. Network analysis of bacteria (A-D). The graphs describe the SparCC correlations between the species abundance in 
parents and children from health and AgP groups (r>0.75, p<0.01). Network analysis of host-bacterial interactions (E-H). The 
graphs describe the Spearman’s correlation between the cytokine’s concentration and the bacteria abundance (p<0.05). The 
green edges represent a positive correlation, while a red edge represents a negative correlation between two nodes. Each node 
represents one bacteria or cytokine and the node size is proportional to the number of correlations presented by it. 
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DISCUSSION   
 The study of a risk population for disease development has been shown to be an important tool 
to investigate pathogenesis and risk markers for disease (Fine et al. 2014). Our group has been using the 
familial aggregation of AgP (one of its major characteristics) to search for a risk group population for 
periodontitis development and to screen for factors possibly associated to the periodontal breakdown 
and to the etiology of AgP. Some studies suggest that the familial aggregation of cases is between 40-
50% (Meng et al. 2011; Michalowicz et al. 2000) which increase the chance of finding susceptible 
subjects with the study design of parents and their children. Meanwhile, also in this pre-disease status, 
this study design was able to show microbial and inflammatory alterations on children from AgP parents 
when compared to children from health parents, even in mixed dentition and young age. Particularly for 
this study, many differences between AgP and health groups and a strong correlation between parents 
and their children subgingival environment were demonstrated, suggesting that these similarities 
between parents-child could be a condition associated to susceptibility and disease development.  
 The influence of parents’ microbiome, especially mothers, in the microbiome composition of 
their children is widely described in the literature and it impacts many body sites, such as oral and gut 
(Mason et al. 2018; Makino 2018; Ferretti et al. 2018; Shaffer and Lozuponea 2018). It was also 
demonstrated that the similarity between environments is higher as higher is the contact between the 
microbial communities (Drell et al. 2017). This can support the vertical transmission (transmission from 
parents to their children) of microorganisms as an important way of oral microbiota acquisition once 
close contact and the hygiene, feeding and social habits were shared between family members. In the 
present study, the similarity between parents-children microbiome was demonstrated and the 
subgingival microbiological alterations were evident in the AgP group, suggesting a strong impact of 
the familiar periodontal status on the oral condition of their children. Regarding the β-diversity, a 
different diversity was identified between AgP and health groups, while a similar diversity was observed 
between AgP parent and their children and between health parents and their children. In terms of 
bacterial abundance, it was possible to observe a great number of differently abundant bacteria when 
the groups were compared. Interestingly, the differences between groups (AgP versus Health) were 
much higher than in the comparison of parents-children from the same group. Especially when children 
from AgP and health groups were compared using the DESeq2 analysis, bacteria belonging to 
Capnocytophaga, Leptotrichia, Prevotella, Treponema, Tannerella genera (mainly gram-negatives and 
anaerobes genera associated to high pathogenicity of the biofilm (Díaz and Kolenbrander 2009; Wade 
2013)) were increased in children form AgP group. All together highlights the great influence of the 
parents’ microbiome on the composition of their children subgingival microbiome and that the early 
colonization by harmful microorganisms could be crucial for the emergence of a dysbiotic community 
related to the periodontal breakdown.  
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 The core, the shared species, and the source tracker analysis demonstrated the similarity between 
a parent and his child microbiome. It was identified that 82% of the species from children from AgP 
parents were also presented in their parents and that the impact of the parent-child similarity is greater 
in AgP families than in healthy families. Furthermore, 50% of the child’s microbiome is estimated to 
come from the analyzed parent, a higher estimation than when a child and a non-related adult were 
compared, reinforcing the importance of bacterial transmission between family members. Other studies 
have also demonstrated the influence of the maternal/family oral microbiota on their child’s microbiota, 
influencing the transmission of some specific microorganisms and the similarity of the whole 
microbiome (Monteiro et al. 2014; Pähkla et al. 2010; Mason et al. 2018; Tamura et al. 2006). Mason 
et al (Mason et al. 2018), for example, demonstrated how the core microbiome of a child is highly 
influenced by the core microbiome of his mother, which is in agreement with our study that revealed a 
high similarity between parents and children, especially in diseased pairs. The core species denote to a 
representative feature of the studied population and they play a structural important to the composition 
on the microbiome and the functionality of that community (Huse et al. 2012; Turnbaugh et al. 2007; 
Bjork et al. 2017). Among the bacteria present on the exclusive core for AgP group it was possible to 
identify Filifactor alocis, S. parasanguinis, F. nucleatum, and Selenomonas genera shared between 
parent and children, while P.gingivalis was exclusive for AgP children and T. forsythia was exclusive 
for AgP parents. These bacteria were usually associated with a more pathogenic environment and more 
specifically with aggressive periodontitis. Interestingly, Filifactor alocis and S. parasanguinis, in 
association with A. actinomycetemcomitans, participate of a consortium associated to an early bone loss 
in adolescents and associated to high risk to aggressive periodontitis (Fine et al. 2013). That way, the 
subgingival environment of patients with AgP and their offspring is been driven for disease-associated 
periodontal bacteria, which could be determinant for the establishment of a dysbiotic microbiota and to 
be related to disease initiation and maintenance. 
 Regarding the importance of some microorganisms to the formation of a dysbiotic microbiome, 
Hajishengallis et al have suggest the importance of P. gingivalis and other keystone pathogens (such as 
Aa for aggressive forms of periodontitis) in modify the subgingival environment, subvert the host 
immune response and stimulate the transition of an eubiosis to a dysbiosis (Hajishengallis, Darveau, and 
Curtis 2012; Hajishengallis and Lamont 2012). The keystone pathogens, even in low abundance in the 
environment, can elevate the virulence of the entire community, support the growth of some 
“inflammophilic” bacteria and stabilizes the dysbiotic associated microbiota, which could lead to 
changes in the host-microbe crosstalk sufficient to initiate chronic, non-resolving inflammatory disease 
(Hajishengallis and Lamont 2012; Hajishengallis 2014). Thus, once a dysbiotic microbiome is 
established, intense stimulation of the immune system can be a trigger and break the balance between 
the host and the microbial aggression, reflecting in the clinical condition.  
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In the present study, the alteration in the microbial composition was accompanied by clinical 
inflammation and the more intense correlation between the bacteria presented subgingivally and the 
cytokines released in the GCF. Interestingly, when the cytokines were analyzed in conjunction with the 
microbial data, using the network analysis, different patterns in the way the host interact with the 
subgingival aggressions were demonstrated between health and AgP groups. The co-occurrence network 
analysis revealed an intense correlation between the bacteria in healthy parents, where some hubs were 
formed, but all of them were intensively connected with positive and negative correlations, suggesting 
a high complexity and self-control of the bacteria correlation. This biofilm generated a small number of 
correlations with the cytokines in the healthy parents, which could represent a small stimulation of the 
inflammatory response. In the AgP condition, on the other hand, the dysbiotic biofilm presented in 
disease was poorly connected itself, even though a higher number of cytokines-bacteria correlations 
were noted. It could represent that in AgP subjects, the biofilm was able to produce a high stimulation 
of the immune system, which could promote an unbalance on the homeostasis between the host and the 
aggression and be directly correlated to the periodontal destruction (Hajishengallis and Lamont 2012). 
Interestingly, the same pattern was identified in the children. In healthy children, more complex 
correlations were demonstrated in the species network while in AgP children more intense host-bacterial 
correlations were presented. It is important to highlight that, even though the children from AgP parent 
presented fewer complex correlations than their parents, the same pattern could be observed between 
parents-children. That way, it was demonstrated that the biofilm composition, as well as its interaction 
with the host response, are altered in AgP descendants, and this unbalance between the biofilm 
aggression and the inflammatory response, even before the disease occurrence, could be one of the key 
points of periodontitis pathogenesis and reinforce the familial aggregation aspect of AgP.  
Regarding the clinical data, the subgingival environmental alterations presented in AgP subjects 
and their descendants reflected in their clinical condition. The children from AgP parents, even with no 
clinical diagnose of attachment loss or bone loss, presented higher PD and BoP. These results 
corroborated with previous studies showing alterations in the clinical condition in children from 
periodontitis parents (Monteiro et al. 2015; Pähkla et al. 2010). The worst periodontal condition can be 
associated with the presence of a dysbiotic microbiome and the more intense stimulation of the 
inflammatory response producing initial clinical signs of periodontal disease. At the same time, the 
higher PD and BoP could favor the establishment of a more pathogenic subgingival environment by 
creating a hyper inflamed and more anaerobic environment and favoring the transition to a dysbiotic 
microbiome (Kenney and Ash 1969; Díaz and Kolenbrander 2009; Loesche et al. 1983). Thus, the 
clinical data reinforces the microbial results and the host-bacterial interactions identified and 
demonstrates how these conditions could interfere in the periodontal health of these subjects.  
Although this study points to the early acquisition of a pathogenic microbiome by vertical 
transmission and its transition to a dysbiotic community as a possible factor associated with familial 
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aggregation of cases of AgP, it is still necessary to understand if and what host factors could be related 
to dysbiosis, and what genetics and behavioral factors can alter the microbial composition and the host 
response to the aggression. Nibali et al, for example, demonstrated how a polymorphism in the IL-6 
gene can affect the colonization for P.gingivalis and Aa (Nibali et al. 2007), another study correlated 
the host’s genetic profile with the occurrence of pathogens associated to periodontal disease (Cavalla et 
al. 2018), and some results in mice also suggested that an alteration in the genetic background is able to 
produces dysbiosis and periodontitis (Eskan et al. 2012). These results support that the host genetics 
also promotes a selective pressure on the microbiota (Hajishengallis 2014), and by altering the host 
response or the inflammatory pattern locally it could produce the ecologic conditions necessary for the 
outgrowth of specific pathogens and the dysbiosis occurrence (Lamont, Koo, and Hajishengallis 2018). 
That way, it is still unclear if the dysbiosis is the cause or the effect of the periodontal disease process 
(Hajishengallis 2014).  Despite the origin, dysbiosis and inflammation act in positive feedback and once 
this cycle is established one can exacerbate the other, to break the subgingival homeostasis and to 
produce periodontal disease.   
A more pathogenic subgingival environment since childhood can increase the risk for the 
periodontal disease development (Höglund Åberg et al. 2014; Shaddox et al. 2012), once it could, in a 
long-term, trigger the periodontal breakdown and clinical attachment loss (Kinane, Stathopoulou, and 
Papapanou 2017). Thus, the evidence that the parent’s periodontal status can affect the periodontal 
condition of their children should be an important tool in the clinic focusing on prevention, early 
diagnose and clinical management of this population. The clinician should be aware of the high-risk 
population to disease development and should focus the attention on monitoring and early diagnose. The 
family members of an AgP subject should be informed about their risk and oriented about hygiene 
methods to prevent plaque accumulation. In addition, they should also be screened and periodically 
examined, once the early diagnose of incipient lesions make the treatment easy and more predictable 
than severe cases (Kinane, Stathopoulou, and Papapanou 2017). This study demonstrated that the 
alteration on the subgingival environment happened in early ages, however, it is still unclear in which 
phase the acquisition of a more pathogenic microbiome happen, what is the clinical impact of this 
microbiota longitudinally and if there is an approach to control this early colonization, which should be 
the focus of next studies.  
 The present study was delineated and developed according to the American Academy of 
Periodontology periodontal disease classification of 1999 (Armitage 1999), however, a new 
classification was released in 2018 (Caton et al. 2018). The AgP patients selected on our study were 
now classified as stage III-IV, grade C periodontitis patients, with no systemic condition associated and 
a rapid rate of progression of periodontal lesions. Despite no mention to the familial aggregation were 
done on the new classification, the familial aggregation of more severe and rapidly progressive 
periodontitis was extensively described in the previous literature (Meng et al. 2011; Nibali et al. 2008; 
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Vieira and Albandar 2014; Albandar 2014; Michalowicz et al. 2000) and this study reinforces the 
importance of this feature on future studies and on disease management. Anyhow, this study brings new 
ideas about how to understand the periodontal disease and its multifactorial nature, suggesting the 
importance of the whole microbiome (instead of some specific bacteria) to characterize the disease, and 
the importance of bacterial behavior and host-bacterial interactions on the subgingival environment.  
 In conclusion, a strong relationship between the parent and their children periodontal condition 
was demonstrated and the transmission of that characteristics can be related to the familial aggregation 
of severe cases of periodontitis. Furthermore, the microbiome, as such as their relationship to the host 
immune system, is altered in diseased parents and their children, what may be associated with 
periodontitis pathogenesis. 
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ABSTRACT 
Background: Pathogenic microbiota acquisition combined with altered host-response during childhood 
can increase the risk to periodontitis and can be associated with the familial aggregation of aggressive 
periodontitis (AgP). Controlling this microbiome through biofilm control is the landmark to prevent 
progressive periodontitis. Thus, this study aimed to evaluate the effect of the plaque control on the 
microbiome and the inflammatory response in children from periodontitis-affected parents. 
Materials and methods: 18 children (6-12 years old) from GAgP parents and 18 from periodontally 
healthy parents were selected. All subjects were periodontally examined and subgingival biofilm and 
gingival crevicular fluid (GCF) were collected at baseline and after 3 months of strict plaque control. 
Next-generation sequencing and bioinformatic tools were used to evaluate the subgingival microbiome 
and the Luminex/MAGPIX platform was used for the inflammatory analysis in GCF. 
Results: Linear Discriminant Analysis of Morisita-Horn index demonstrated two massive clusters 
separating children from AgP parents from children from healthy parents (Adonis test, p=0.014), 
demonstrating a significant impact of parental periodontitis on the microbiome of their descendants. A 
more pathogenic microbiome associated with more intense host-bacterial interactions were identified in 
children from AgP parents. The dysbiotic microbiome of AgP descendants showed a strong resilience 
against shifting after plaque control, maintaining the diversity and the richness of disease-associated 
species even after the clinical benefits achieved. In addition, plaque control was not able to alter the 
pattern of host-bacterial interaction in the subgingival environment. 
Conclusion: Besides the dysbiotic microbiome and the more pathogenic subgingival environment 
identified in AgP descendants, children from periodontitis-affected parents presented a strong resilience 
to subgingival microbial shifting after strict plaque control, highlighting the higher risk for disease 
development.  
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INTRODUCTION 
The familial aggregation is one of the most important features of Generalized Aggressive 
Periodontitis (GAgP), nowadays classified as periodontitis grade C (Caton et al. 2018), a multifactorial 
inflammatory disease in the periodontal tissue caused by an unbalance between the subgingival 
microbial aggressions and the host response (Lamont et al. 2018). Some studies have demonstrated that 
the aggregation of cases in the same family turns around 50% (Michalowicz et al. 2000; Meng et al. 
2011). Many aspects, such as transmission of bacteria, genetical and behavioral factors, transmission of 
susceptibility factors associated with microbial colonization and host response (Haubek 2010; Könönen 
and Müller 2014; Vieira and Albandar 2014), can affect the risk of a subject to develop periodontitis 
and the accumulation of susceptibility aspects can increase the accumulation of cases within families. 
This way, children from parents affected for GAgP can be considered higher risk population to develop 
the disease and the study of this group could be important for understanding the disease etiology, the 
susceptibility factors and risk markers for periodontal disease.  
Studies have been demonstrating that the periodontal condition of GAgP parents affects the 
subgingival environment of their children by creating a more pathogenic oral condition even before the 
clinical diagnose of disease and the periodontal destruction (Monteiro et al. 2014; Monteiro et al. 2015; 
Monteiro et al. 2019). Higher colonization by A. actinomycetemcomitans (Aa), an established 
periodontal pathogen, in saliva (Monteiro et al. 2014) and subgingival environment (Monteiro et al. 
2015), as well higher levels of clinical inflammation were identified in children from GAgP parents 
when compared to children from health parents (Monteiro et al. 2015). Furthermore, the parents’ 
microbiome strongly impacts the microbial composition of their offspring and the GAgP associated 
subgingival microbiome was associated with dysbiosis, higher colonization for pathogens and more 
intense host-bacterial interactions (Monteiro et al. 2019). Thus, this more pathogenic subgingival 
environment since childhood could represent a risk to periodontitis development, being involved in 
susceptibility and etiology of periodontitis.  
These results highlight the importance of the monitoring of this higher risk population and the 
need for preventive approaches to control/avoid the establishment of a more pathogenic microbiota, 
higher levels of inflammation and the clinical impact of this alterations. The plaque control is the most 
widely recommended approach to control the biofilm accumulation and the precocious clinical changes 
in the periodontal tissue, especially in children, when an invasive approach usually is not necessary. The 
experimental gingivitis studies have demonstrated how the biofilm control is efficient to reduce 
gingivitis and establish the periodontal health (Löe et al. 1965; Trombelli et al. 2004), however, the 
impact of the supragingival intervention in controlling the dysbiotic subgingival microbiota, specifically 
in a higher risk population, is unclear. Therefore, this study was designed to evaluate the efficiency of 
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plaque control in controlling the clinical, microbiological and inflammatory subgingival condition of 
children from GAgP parents. 
 
MATERIAL AND METHODS 
 This study was approved by the local ethical Commit of Piracicaba Dental Scholl, University of 
Campinas, Brazil, process 079/2013, where the study was conducted. The study was designed as an age- 
and gender-matched, case-control clinical trial.  
 Eighteen children from GAgP parents and 18 from health parents were selected to compose the 
groups: 
- GAgP group:  children aged 6 to 12 years, presenting the permanent first molars and incisors, with at 
least one of the parents diagnosed with GAgP.  
- Health group: children aged 6 to 12 years, presenting the permanent first molars and incisors, with 
both parents periodontally healthy. 
 The parents diagnose respected the following criteria:   
- GAgP parents: i) Less than 35 years old at the diagnosis; ii) at least 8 teeth with probing depth (PD) 
and clinical attachment level (CAL) > 5mm (with at least 2 sites with PD > 7mm) at diagnosis; iii) at 
least 20 teeth in the oral cavity; iv) good systemic health v) no smoking habits; vi) been in periodontal 
supportive therapy for at least 6 months. (Monteiro et al. 2015). 
- Health parents: i) Good systemic health; ii) at least 20 teeth in the oral cavity; iii) absence of periodontal 
pockets/gingival sulcus with PD > 4mm; iv) absence of proximal bone loss; v) no smoking habits. 
(Monteiro et al. 2015). 
 The exclusion criteria for children were: i) absence of good systemic health; ii) the use of 
antibiotics and anti-inflammatory medication 6 months prior to the study; iii) alteration in the motor 
condition that modifies the brushing habits;  
 All children were included in the strict plaque control program for 3 months. At baseline, 
children were clinically evaluated and samples of subgingival biofilm and gingival crevicular fluid 
(GCF) were collected. Additionally, they received professional plaque control and oral hygiene 
orientation that include brushing with Bass technique 3 times per day and flossing. The monitoring and 
the reorientation of hygiene habits were repeated one month later. Three months after the beginning of 
plaque control, all children were reassessed for their clinical condition and for sample collections. 
 The children were clinically assessed for the plaque index – PI (Ainamo and Bay 1975), gingival 
index – GI (Ainamo and Bay 1975), probing depth – PD (a distance of gingival margin to the bottom of 
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periodontal pocket/sulcus), bleeding on probing – BoP (Mühlemann and Son 1971). The examination 
was performed by an experienced and calibrated examiner (MFM - Intra-class correlation=92% of PPD). 
Microbiome analysis 
 Subgingival biofilm was collected from 2 incisors and 2 first molars of children by the same 
examiner (MFM) that carried out the clinical evaluation. The collected sites were the ones with the 
deepest PD of one molar and one incisor of superior arcade and one molar and one incisor of the inferior 
arcade. Following supragingival biofilm removal and relative isolation with cotton rolls, a sterile paper 
point (Nº35) was inserted into the bottom of the periodontal pocket/gingival sulci for 30s. The paper 
points were placed into sterile tubes containing 300 μL of Tris-EDTA 0.5mM and reserved in -20C until 
laboratory evaluation.  
Plaque samples were removed from the paper points by adding 200 ml of phosphate buffered 
saline (PBS) and vortexed for 1 minute. The paper points were removed, and DNA isolated using a 
Qiagen MiniAmp kit (Valencia, CA) according to the manufacturer’s instructions. The regions V1-V3 
and V4-V5 of the 16S rRNA genes were sequenced using the Illumina Miseq platform. The library 
generation was done using an Illumina TruSeq DNA sample preparation kit according to the 
manufacturer’s instructions. Genomic DNA was enzymatically sheared yielding an average fragment 
size of 500 base pairs. The fragment ends were blunted and adenylated, before ligation of barcodes and 
sequencing adaptors. The adaptor-ligated sequences were enriched with 10 cycles of PCR with included 
Illumina primers before the libraries are quantified and pooled. Pooled libraries were clustered on the 
MiSeq, and 300bp paired-end sequencing was performed according to the manufacturer’s protocols. 
The Illumina base-calling pipeline was used to process the raw fluorescence images and call sequences. 
Raw reads with >10% unknown nucleotides or with >50% low-quality nucleotides (quality value <20) 
was discarded.  
Processing pipeline:  
Analyses were conducted using the QIIME (Caporaso et al. 2010) and PhyloToAST (Dabdoub et al. 
2016). Sequences with an average quality score of 30 over a sliding window of 50bp and length >200 
bp were assigned a taxonomic identity by alignment to the HOMD database (Chen et al. 2010) using the 
Blastn algorithm at 99% identity. The chao1 method was used as estimators of alpha diversity, and 
differences between alpha diversities group-wise were measured using the Kruskal-Wallis test. The 
Morisita-Horn dissimilarity distance matrices were used to estimate beta diversity. Linear Discriminant 
Analysis (LDA) was performed on distance matrices, and significance of clustering was interrogated 
using Adonis with 999 permutations. LDA plot and confidence ellipses were generated by the R package 
ggplot. Core species were identified using Qime’s script (core_microbiome.py) when species were 
present in at least 75% of the patients in each group. The Bioconductor package for R, DESeq2, was 
used to perform differential expression analysis of the annotated taxa (Love et al. 2014). This function 
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uses a negative binomial distribution of raw counts to estimate between-group differences while 
accounting for sampling effort (library size) and dispersion of each category (taxon or functional gene). 
p-values were adjusted for multiple testing (FDR < 0.1, FDR-adjusted Wald Test). The proportion of 
the bacterial abundance regarding the gram status and oxygen requirement was calculated using Python 
scripts (gramox_calc.py and pct_abd_gramox.py). 
Cytokine profile assessment using multiplexed bead immunoassay (Luminex) 
Gingival crevicular fluid (GCF) was collected from the same site the subgingival biofilm was 
collected by the same examiner (MFM) that carried out the clinical evaluation. After the biofilm 
collection, the area was isolated, dried and GCF was collected by placing filter paper strips (Periopaper, 
Oraflow, Plainview, NY, USA) into the pocket until the clinician perceived a slight resistance, and then 
leaving in place for 15 s. The fluid volume was measured with a calibrated device (Periotron 8000, 
Oraflow, Plainview, NY, USA). The strips were placed into sterile tubes containing 100 μL of 
phosphate-buffered saline (PBS) with 0.05% Tween-20. GCF samples were immediately stored at -20°C 
until multiplexed using a bead immunoassay assay. 
Cytokine levels of interleukin (IL)-10, IL-17, IL-1β, IL-8, IL-4, IL-6, interferon (IFN)-γ and 
tumor necrosis factor (TNF)-α) in GCF were determined using the Sensitivity Human Cytokine 08-plex 
(Millipore Corporation, Billerica, MA). Assays were performed according to the manufacturer’s 
recommendations using the MAGpix™ equipment (MiraiBio, Alameda, CA). The samples were 
collected as a pool and concentrations were estimated from the standard curve using a five-parameter 
polynomial equation using Xponent® software (Millipore, Corporation, Billerica, MA). The calculation 
of the mean concentration of each cytokine was performed using the individual as a statistical unit and 
was expressed as pg/ml. 
For the statistical analysis, the normality was tested with the Shapiro-Wilk test, and the data 
were normalized using the log transformation when necessary. Once normal distribution was obtained 
the Student’s t-test was used to test the differences in the cytokine’s concentration in the Health and 
GAgP groups. The cytokine concentration was correlated with the bacterial abundance data. The 
cytokine-bacterial network correlations were determined by significant pairwise using Spearman’s 
correlation (p<0.05, ρ>0.6) and the result was visualized in Gephi software (Bastian et al. 2009)  
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RESULTS 
 The total of 18 children per group participated in the plaque control program and was included 
in the analysis. The clinical data is demonstrated in table 1. It is possible to observe that the proposed 
therapy was effective in controlling the clinical parameters initially different at baseline. At baseline, 
GAgP group presented higher BoP (p=0.012) and PD (p=0.013). The plaque control reduced the PI for 
both groups (GAgP p=0.003 and health p<0.001), and a benefit was only observed in the GAgP group 
in a reduction in the GI (p=0.003) and PD (p<0.001).  After 3 months controlling for plaque, no 
differences were observed between groups (p>0.05). 
 
Table 1. Demographic data and clinical parameters of GAgP and Health groups at baseline and after 3 months of 
plaque control. 
  
 
Baseline 3 months 
Gender 
 (% female) 
GAgP 44.4 - 
Health 44.4 - 
Age  
(years±SD) 
GAgP 9.7±2.16 - 
Health 9.55±1.97 - 
PI  
(%±SD) 
GAgP 55.7±13.9 32.8±17.3 * 
Health 50.6±22.1 36.4±14.6 * 
GI  
(%±SD) 
GAgP 24.8±13.2 17.3±8.0 $ 
Health 20±12.1 20.6±13.5 
BoP  
(%±SD) 
GAgP 37.3±14.4 33.9±13.6 
Health 25.8±12.1 # 25.3±13.9 
PD site 
(mm±SD) 
GAgP 3.5±0.47 3.0±0.42 $ 
Health 3.2±0.30 # 3.0±0.42 
Symbols indicate statistical differences: between groups # (Student’s T-test), between time points within groups * (Wilcoxon 
test) and $ (paired Student’s T-test) (p<0.05). 
 
 The inflammatory data is described in table 2. At baseline, no differences were observed 
between groups. The plaque control promoted a minimum effect in the cytokine concentration. No 
changes were observed in the health group and an increase of IL-8 was observed in GAgP descendants. 
At 3 months after plaque control program beginning, no differences were observed between groups.  
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Table 2. Cytokine concentration (pg/µl) in the gingival crevicular fluid for GAgP and Health groups at baseline 
and after 3 months of plaque control. 
 Baseline 3 months 
IFNy 
GAgP 15.75±16.64 12.63±10.17 
Health 17.16±21.9 17.03±12.32 
IL-10 
GAgP 23.6±23.08 19.87±13.63 
Health 18.43±15.55 20.99±13.89 
IL-17 
GAgP 8.07±7.08 8.2±6.96 
Health 8.65±9.51 10.22±8.6 
IL-1b 
GAgP 18.29±20.22 15.21±10.81 
Health 11.35±10.59 12.02±6.52 
IL-4 
GAgP 17.91±17.15 15.62±10.05 
Health 13.16±10.61 16.88±16.41 
IL-6 
GAgP 13.54±7.82 17.7±15.56 
Health 12.29±9.61 16.2±11.42 
IL-8 
GAgP 841.68±553.39 1229.15±645.37 * 
Health 814.87±575.12 1005.86±657.68 
TNF-a 
GAgP 14.45±12.29 14.55±7.87 
Health 10.62±8.08 13.08±8.01 
* indicate statistical differences between time points within groups (paired Student’s T-test, p<0.05). 
 
Figure 1 describes the effect of plaque control in the diversity indexes. The Alpha diversity 
analysis of the Chao1 estimator (1A) describes the within sample differences between GAgP and health 
groups and the reduced effect of control of plaque in change the microbial pattern of this children. The 
aggressive group presented a higher diversity than health group in the baseline (p=0.022) and after 3 
months of control of plaque (p=0.0003). Furthermore, no difference was observed between baseline and 
3 months in health (p=0.97) and GAgP groups (p=0.081). PCoA of Bray-Curtis similarity index (Fig 
1B) and LDA of the Morisita-Horn index (Fig 1C) demonstrated the formation of two clusters separating 
the GAgP and the Health subjects, however, no separation was observed between the baseline and 3 
months samples. There were statistical differences between GAgP and health at baseline and at 3 months 
(p<0.05), while no difference was noted between baseline and 3 months in GAgP (Bray-Curtis distances, 
p=0.632; Morisita-Horn distances, p=0.484) and health (Bray-Curtis distances, p=0.66; Morisita-Horn 
distances, p=0.546). Despite no statistical difference between baseline and 3 months, there was a 
graphical difference between time points in health group, which was not observed for GAgP, suggesting 
a possible higher effect of the plaque control in health than in GAgP. This way, plaque accumulation 
control was not efficient to reduce the subgingival microbial differences between groups after 3 months 
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(p=0.001). The proportion of microorganisms regarding the gram status and oxygen requirements was 
represented in figure 1D. No difference was reported at baseline. The plaque control increased the 
proportion of gram-positive facultative in the health group (paired Student’s T-test, p=0.02). At 3 
months after plaque control, GAgP groups presented a higher proportion of gram-negative anaerobes in 
the subgingival biofilm (Mann-Whitney test, p=0.01). In health group, there was a trend of a decrease 
of gram-negative anaerobes after plaque control (paired Student’s T-test, p=0.08) and higher levels of 
gram-positive facultative compared to GAgP group (Student’s T-test, p=0.08). In 1E, the core 
microbiome reinforces the differences between groups and the reduced potential of plaque control to 
decrease the differences between GAgP and Health groups. GAgP group presented a high number of 
core exclusive species and bacteria such as F. alocis, S parasanguinis, F. nucleatum, P. gingivalis, and 
T. forsythia (at 3 months), frequently correlated to periodontal disease, were described as exclusive for 
the GAgP. That way, the diversity results indicate a strong effect of the family periodontal status on the 
composition of the microbiome and resilience in the established microbiome diversity, reinforcing the 
impact of initial colonization and host factors in the composition of the microbiome.  
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Figure 1 Differences in microbial diversity between groups and time points. A) α-diversity, Chao1 estimator. B)  β-diversity, 
represented in the PCoA of Bray-Curtis dissimilarity index. C) β-diversity, represented in the LDA of Morisita-Horn 
Dissimilarity Index D) Bacteria relative abundance regarding the oxygen requirement and the gram status calculated for each 
group and time point. * indicates statistical differences between groups and # indicates differences between time points within 
groups (p<0.05).  E) Core microbiome, representing species presented in at least 75% of the subjects of a group. 
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The DESeq2 were used to identify the bacteria differentially abundance between groups (figure 
2). The results were expressed in fold change and the p-value was corrected for multiple comparisons. 
The group's comparison at baseline (2A) demonstrated 98 species differentially expressed (84 increased 
in GAgP children). It was possible to observe a higher abundance of Capnocytophaga, Haemophilus, 
Leptotrichia, Prevotella, Tannerella, TM7, Treponema and Veillonella genera, mainly gram-negatives 
and anaerobes and associated to a more pathogenic environment, were more abundant in GAgP. The 
differences between time points were demonstrated in B and C. The plaque control changed 30 species 
in health and 44 species in GAgP, changing species from diverse genera. It is important to highlight that 
the abundance differences were higher when comparing the GAgP and the health groups than when 
comparing the effect of plaque control (baseline to 3 months), suggesting that the influence of familial 
Figure 2 Differential abundance analysis represented in fold change A) Bacteria differentially abundant between GAgP and 
Health groups at baseline. The red bars represent the bacteria increased in GAgP group and the dark blue bars the bacteria 
increased in the health group. B) Bacteria differentially abundant between baseline and 3 months in Health group. C) Bacteria 
differentially abundant between baseline and 3 months in GAgP group. D) Bacteria differentially abundant between GAgP and 
Health groups at 3 months after the plaque control. 
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periodontal status in the composition of the microbiome is more important than the plaque control when 
the biofilm is already established. Interestingly, in the species-level analysis, the plaque control 
accentuated the differences between children from health and GAgP groups at 3 months (2D) and 162 
species were found to be differentially expressed, with 144 more abundant in GAgP. Most of this species 
increased in GAgP were representative of gram-negative and anaerobes genera similarly as the baseline. 
Additionally, important periodontal pathogens, such as A. actinomycetemcomitans, Filifactor alocis, 
Streptococcus parasanguinis, Fusobacterium nucleatum, Porphyromonas gingivalis, Treponema 
denticola, Tannerella forsythia, were increased in GAgP at 3 months.  
Regarding the inflammatory results, although no differences on the cytokines levels were 
observed between groups (Mann-Whitney test, p>0.05), the correlation analysis between the microbial 
data and the cytokines showed a clearly different pattern of host-bacterial interactions between familial 
disease history (figure 3). Considering only strong correlations (ρ>0.6), a healthy group at baseline 
presented a hub of interactions between IL-8 and species, and strong correlations were observed between 
cytokine-cytokine. On the other hand, the GAgP children at baseline were characterized for a higher 
number of correlations between bacteria and cytokines, most of that negative correlations, and a reduced 
number of strong correlations between cytokine-cytokine, what suggests more intense relationship 
between the microbiome and the host response and a less orchestrated relationship between the proteins 
responsible for the initial inflammatory response on the subgingival environment. The plaque control 
promoted a reduction in the number of species-cytokine correlation in both groups, however, it was not 
able to change the pattern of host-bacterial interactions demonstrated at baseline. For the health group, 
the strong correlations between all cytokines was maintained and, in the GAgP group, despite an 
increase on the number of cytokine-cytokine correlations, the cytokine-species correlation was still 
strong, demonstrating the effect of microbiome and inflammation on each other and possibly higher 
levels of aggression on the periodontal tissue of children from GAgP parents.  
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Figure 3. Network analysis of host-bacterial interactions. The graphs describe the Spearman’s correlation between the 
cytokine’s concentration and the bacteria abundance (p<0.05, ρ>0.6). The green edges represent a positive correlation, while a 
red edge represents a negative correlation between two nodes. Each node represents one bacteria or cytokine and the node size 
is proportional to the number of correlations presented by it. 
 
DISCUSSION 
 Periodontitis is a complex disease and understand its etiological and pathogenic aspects, as well 
the factor associated with susceptibility to disease, is essential for the correct management and specific 
treatment of the affected subjects (Kinane et al. 2017). The study of a risk population to develop the 
disease, as is the case of descendants of GAgP patients, have been demonstrated to be an interesting 
approach for the comprehension of periodontitis. It allowed the identification of periodontal conditions 
altered previously to the periodontal breakdown, which could be associated to susceptibility to disease 
and the periodontitis pathogenesis (Monteiro et al. 2014; Monteiro et al. 2015; Monteiro et al. 2019). 
The present study, besides demonstrating subgingival alterations as consequence of familial origin and 
identifying factors associated to risk to disease, demonstrated that the plaque control regimen proposed 
in this study, even controlling the clinical parameters, was not enough to change the more pathogenic 
subgingival environment in the risk population, suggesting a strong intrinsic factor in the determination 
of the periodontal condition.  
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 The baseline condition demonstrated in this study corroborate with a previous analysis that 
identified a negative effect of the periodontal condition of GAgP families in their offspring (Monteiro 
et al. 2019). In the present study, children from GAgP parents presented higher PD and BoP, and the 
worst clinical condition was related to subgingival dysbiosis, higher frequency of pathogens in the 
biofilm and the more intense correlation between the microbiome and the inflammatory condition. These 
periodontal characteristics are compatible with the most recent explanation of periodontal disease 
pathogenesis that suggested that the dysbiosis associated with alterations in the host-bacterial 
interactions can produce an unbalance between the microbial aggression and the host immune response, 
causing the periodontal breakdown (Lamont, 2018). Thus, the recent findings suggest that this 
characteristics can increase the risk to GAgP descendants to also develop periodontitis and the 
comprehension of this pathogenic environment can be the key point to understand the disease 
susceptibility. Furthermore, the comprehension of risk reinforces the necessity of monitoring, preventive 
activities and more specific therapeutic approaches to the population.  
 The plaque control and the oral hygiene instruction are the first choices and the most 
recommended therapy to prevent/control conditions associated to plaque accumulation in the oral cavity, 
especially in children during mixed dentition (Hilgert et al. 2017; Kinane et al. 2017). Controlling the 
plaque accumulation and gingival inflammation is a non-invasive approach, essential to achieve oral 
health in a long-term period (Lang et al. 2009). The benefits of plaque removal for the periodontal 
healthy were confirmed by the experimental gingivitis studies, which demonstrated that the complete 
removal of biofilm from the gingival margin is enough to control the gingival inflammation and 
obtaining the clinical healthy gingiva (Löe et al. 1965; Trombelli et al. 2004). The clinical beneficial 
effect of plaque removal and tooth brushing were also achieved in this study. It was able to reduce the 
plaque accumulation for all children and an additional reduction of PD and GI in the GAgP group, 
eliminating the clinical differences between groups. However, even controlling the clinical alterations, 
the subgingival changes observed in the study were minimal, and they were not enough to modify the 
microbial pattern presented at baseline. The plaque control does not affect the alpha and the beta 
diversity of both groups and the core microbiome, composed by species highly frequent and with a 
probable structural and functional importance to the microbial community (Turnbaugh et al. 2007; Huse 
et al. 2012; Bjork et al. 2017), was maintained from baseline to 3 months of plaque control. Interestingly, 
in terms of bacteria differentially abundant, the familial origin could be considered dominant once 
plaque control induced only minor differences, highlighting the strong and important role of the familial 
background and the host factors in the determination of the oral microbiota. In addition, a reduced effect 
in the host-bacterial interaction was observed. Both groups presented a reduction in the number of 
correlations between the bacterial abundance and the cytokine concentration, however, the alterations 
were not enough to change the patterns observed at baseline. In GAgP group, a higher number of 
correlation species-cytokines were observed, suggesting higher levels of aggression in the subgingival 
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environment. Otherwise, in a healthy group, and a strong correlation between cytokines were observed, 
suggesting a balance between the molecules associated with periodontal inflammation. Thus, the plaque 
control was not effective to change the disease-associated pattern presented by GAgP descendants, 
maintaining the pathogenic subgingival environment and the risk associated with it.  
 Meanwhile, although the subgingival condition appears to be resistant to change, the plaque 
control could promote some specific alterations. Plaque and gingival indexes reduction after 3 months 
of strict control led to more effects in the health group than in the GAgP group. The relative abundance 
analysis of species regarding their gram status and oxygen requirements revealed an increase in the 
proportion of gram-positive facultative in the health group after plaque control. Moreover, a trend of 
reduction in the proportion of gram-negative anaerobes was also observed in health, while no alteration 
was identified in the GAgP group. The LDA graph (figure 2C) also suggested a higher influence of 
plaque control in the health groups by demonstrating a slight separation in the microbiome of health 
baseline and 3 months samples while the GAgP samples were all clustered together independent of the 
hygiene intervention. Therefore, these results suggest that the disease-associated 
microbiome/subgingival environment of GAgP descendants is more resilient to shift, once minimal 
alterations in the microbial composition were achieved after biofilm removal. Microbial resilience is the 
property of the microbial community that determines how fast, and to what extent, it will recover the 
initial taxonomic and functional structure after perturbation (Holling 1973). This aspect is an ecological 
property of the microbiomes, both in a symbiotic and in a dysbiotic state, that achieving the ideal 
environmental conditions and equilibrium in the metabolic, nutritional and spatial requirements, get 
more resistant to external interventions (Sommer et al. 2017). In this context the early acquisition of an 
unhealthy and dysbiotic community with a high resilience potential during the childhood (a vulnerable 
period for community acquisition), as suggested in the present study, may contribute to periodontitis 
occurrence, at the same way it contributes to the chronicity of other dysbiosis-associated diseases (e.g. 
obesity, metabolic syndrome) (Sommer et al. 2017). Furthermore, the genetic pressure in the 
microbiome and the host factors can also be determinants to the maintenance of the microbiome and the 
ecological conditions in GAgP subjects/descendants (Nibali et al. 2007; Nibali et al. 2013; Lamont et 
al. 2018), reducing the importance of the decrease of plaque accumulation on the composition of the 
community. 
 Despite the reduced effect in the microbial community, the plaque control was responsible for 
increasing the differences between groups, probably a result of the changes demonstrated in the health 
condition. The DESeq2 results of the comparison between groups at 3 months revealed an increase in 
the number of bacteria differentially abundant, 144 were more abundant in GAgP and all pathobionts 
linked to periodontal disease or to risk to future periodontal breakdown, such as A. 
actinomycetemcomitans, Filifactor alocis, Streptococcus parasanguinis, Treponema denticola,  
Fusobacterium nucleatum, Porphyromonas gingivalis, Tannerella forsythia were more abundant in 
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children from periodontitis parents. More specifically, A. actinomycetemcomitans, F. alocis and S. 
parasanguinis, bacteria identified as a consortium related to risk and future bone loss in adolescents 
(Fine et al. 2013), were identified as more abundant and as part of the core microbiome in GAgP. 
Furthermore, the proportion of gram-negative and anaerobes identified in GAgP was higher than in 
health after plaque control. The 3 months results highlighted the dysbiosis of the disease-associated 
microbiome and reinforce the idea that the presence of this pathogenic periodontal conditions since 
childhood can be a risk and can be related to susceptibility and the familial aspects of the most severe 
cases of periodontitis. The dysbiosis and the higher presence of pathobionts can be crucial for the 
intensification of the microbial aggressions and the amplification of the local inflammatory response, 
breaking of the periodontal homeostasis and producing periodontal destruction (Lamont et al. 2018).  
 This study demonstrated that the control for plaque accumulation, the most used preventive 
approach to prevent an oral condition associated to biofilm, is not enough to control the higher 
pathogenicity of the subgingival environment in a risk population to periodontitis development. 
Additionally, it underlines that the familiar effect on the microbial condition is higher than the impact 
of plaque control, suggesting that the periodontal pathogenesis is more related to host/colonization 
factors than just the absence of ideal oral hygiene. Thus, the present findings should be applied to the 
dental clinic to allow the appropriate management of the population with increased risk to periodontitis. 
The GAP patient should be aware of the risk to their relatives to also develop the disease and of the need 
for periodic monitoring. The clinicians should assess risk and the familial component of periodontal 
disease during the clinical evaluation and they should include the risk population in a rigid monitoring 
and preventive activities focusing in controlling the precocious alteration and in the early diagnose. 
Moreover, more effective approaches should be proposed to control the dysbiosis and the early 
colonization for pathogenic microorganisms, as well to modulate the host response to the microbial 
aggression, once the comprehension of the community aspect allows a specific intervention in the 
disease drivers and in the microbial resilience (Rosier et al. 2018). This study offers an insight about the 
identification of a risk population and susceptibility for periodontitis, besides the comprehension of 
pathogenic aspects of periodontal destruction, however, it is still necessary a long-term evaluation of 
the studied group to understand the real impact of the observed alterations and the identification of 
etiological components and biomarker for periodontal disease.   
 In conclusion, besides the dysbiotic microbiome and the more pathogenic subgingival 
environment identified in GAgP descendants, children from periodontitis-affected parents presented a 
strong resilience to subgingival microbial shifting after strict plaque control, highlighting the higher risk 
for disease development. 
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Abstract  
Objectives: Studies have demonstrated that children from Aggressive Periodontitis (AgP) parents 
presented precocious alterations in their periodontal condition. This study aimed to evaluate the effect 
of Triclosan toothpaste to modulate the clinical and subgingival condition in children from AgP parents.  
Methods: 15 children from AgP parents and 15 from periodontally healthy parents were included in this 
cross-over placebo study. Children were randomly allocated into Triclosan or Placebo therapy, using 
selected toothpaste for 45 days. After 15 days of wash-out, groups were crossed changing the used 
toothpaste. In each phase, clinical examination and saliva, crevicular gingival fluid (GCF) and 
subgingival biofilm collection were performed at baseline and 45 days. GCF cytokines’ levels were 
analyzed by Luminex/MAGpix platform and subgingival and salivary periodontal pathogens’ levels by 
qPCR.  
Results: At baseline, AgP group presented higher gingival index (GI), plaque index (PI), and bleeding 
on probing (BoP), higher A. actinomycetemcomitans (Aa) abundance in saliva and subgingival biofilm, 
and lower levels of INF-ɣ, IL-17, IL-4 in GCF. Placebo therapy only reduced PI in both groups. 
Triclosan toothpaste reduced PI and GI in both groups. Triclosan promoted the reduction of BoP and 
PD (probing depth), Aa salivary and IL-1β levels in AgP group. In Health group, Triclosan reduced 
INF-ɣ and IL-4 concentration.  
Conclusion: Triclosan toothpaste demonstrated to be more effective than placebo toothpaste to control 
the periodontal condition in children from AgP parents, by reducing the BoP, PD, salivary Aa, and IL-
1β. 
Clinical Relevance: Triclosan toothpaste can improve oral conditions in higher risk population for AgP.   
 
Keywords: Aggressive periodontitis, family, triclosan, cytokines, Aggregatibacter 
actinomycetemcomitans 
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Introduction 
 Generalized aggressive periodontitis (GAgP) is a multifactorial disease caused by an unbalance 
between the microbial challenge and the host response, in which an exacerbation of the inflammatory 
process in the periodontium stimulate the periodontal breakdown and bone loss [1]. One important 
characteristic of GAgP is the familial aggregation [2], and the sharing of susceptibility factors within 
family members, either by the transmission of microorganisms, genetic factors and/or behavioral aspects 
[3], has been influencing the prevalence around 50% of cases between family members [2]. Thus, 
investigating this highly affected group could be an important approach to understand etiopathogenesis, 
the identification of risk factors and prevention of periodontal disease.  
 Precocious alterations were demonstrated in children from parents affected by GAgP when they 
were compared to children from healthy parents and this condition was observed even before the clinical 
diagnose of periodontitis or bone loss [4, 5]. Children from GAgP parents have presented a higher 
frequency of detection and concentration of A. actinomycetemcomitans (Aa) in saliva when compared 
to children from both parents periodontally healthy and a child has 16 times more risk to be colonized 
by Aa when a parent is Aa positive [4]. Furthermore, children from GAgP parents presented higher 
plaque index, gingival index and probing depth and higher colonization by Aa in the subgingival 
environment, with Aa is been highly correlated to gingival bleeding [5]. In addition, initial data about 
inflammatory condition on the gingival crevicular fluid of those children demonstrated an unbalance on 
the cytokines’ levels and on the host response pathways [6], reinforcing the idea that initial changes can 
be observed precociously even before the clinical signs of periodontal breakdown, that those alterations 
could represent a high risk to that population and that something should be done to control this high risk.  
 The most widely used approach to control the periodontal disease is to prevent the biofilm 
accumulation, the colonization by more pathogenic microorganisms and establish a less inflamed 
subgingival environment [7].  In addition to that, the use of antimicrobial and anti-inflammatory agents 
in association with the plaque control could be an efficient method to improve the clinical and 
subgingival environment alterations. The triclosan-containing toothpaste has demonstrated good 
antimicrobial and anti-inflammatory properties, being efficient in improving the periodontal parameters 
[8–10], reducing pathogens levels, such as Aa and P. gingivalis[11], and in modulating the inflammatory 
response in vitro and in vivo [10, 12]. Moreover, the toothpaste with Triclosan is an easy-to-use and 
secure form of application and would represent no substantial change in the children habits, facilitating 
the accessibility and compliance. Thus, this study aimed to evaluate the efficiency of toothpaste with 
triclosan to modulate clinical, microbiological and inflammatory conditions in the oral cavity of children 
from GAgP families when compared to children from healthy families.  
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Materials and Method 
 Study design 
This study was developed at Piracicaba Dental School, University of Campinas, Brazil, with the 
approval of local ethical Commit, process 103/2015 and it was registered at ClinicalTrials.gov with the 
identifier NCT03642353. This study is a cross-over placebo-controlled clinical trial. Informed consent 
was obtained from all individual participants included in the study. 
Patient selection 
Patients with a history of generalized aggressive periodontitis (GAgP) in supportive periodontal 
therapy were accessed about the inclusion of their children in the study. After the selection of the GAgP 
group, periodontally healthy families (both parents should be periodontally healthy) were accessed about 
the inclusion of their children on the study. GAgP parents were selected respecting the following 
inclusion criteria previously described in the literature: i) Less than 35 years of age at the time of 
diagnosis; ii) at least 8 teeth with probing depth (PD) and clinical attachment level (CAL) > 5mm (with 
at least 2 sites with PD > 7mm) at diagnosis; iii) at least 20 teeth in the oral cavity; iv) good systemic 
health. The healthy parents were selected following the inclusion criteria: i) Good systemic health; ii) at 
least 20 teeth in the oral cavity; iii) absence of periodontal pockets/gingival sulcus with PD > 4mm; iv) 
absence of proximal bone loss [5].  
The inclusion criteria for children were: i) to present parents that respect the inclusion criteria 
for periodontal health or GAgP; ii) to present between 6 and 12 years old at the moment the study begun 
iii) to present good systemic health. The exclusion criteria for children were: i) the use of antibiotics and 
anti-inflammatory medication 6 months prior the study; ii) any alteration in the child's motor condition 
that would affect the performance of oral hygiene procedures. 
Fifteen children from GAgP parents and 15 children from both parents periodontally healthy 
were selected to participate in this study by the researcher MFM. 
 Groups  
 Simple randomization between Triclosan and placebo was done, by the researcher RCVC. The 
toothpaste was named as A (Triclosan) and B (placebo), and the toothpaste packs were only identified 
by the letters. A computer-generated randomization list was used to randomly allocate the toothpaste A 
or B to each child from GAgP and Health groups. That way, neither the children nor the operator 
responsible for conducting the oral hygiene instruction and clinical examination known in which 
toothpaste protocol they were included. 
 The study design was described in figure 1. All children were included in an initial period of 15 
days to standardize oral hygiene procedures. They have received prophylaxis, calculus removal if 
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necessary, oral hygiene instructions and they were oriented to use only the toothpaste and toothbrush 
given by the research team. The children used the Bass technique to brush their teeth three times a day, 
received training to floss each time they brushed, and they were oriented to do not use other hygiene 
procedures or use any kind of mouthwash during the study. During this period, they used the placebo 
toothpaste.  
Figure 1 Study design flowchart. 
 
 After that, the children from GAgP and Health groups were divided into two subgroups, 
respecting the randomization, one using the Triclosan (0.3% triclosan/2.0% copolymer/1450 ppm 
fluoride toothpaste) and one using placebo (1450 ppm fluoride toothpaste). This way, the following 
groups were obtained:  
- Health-Triclosan group: children from periodontally healthy parents using triclosan toothpaste during 
oral hygiene;  
- Health-Placebo group: children from periodontally healthy using placebo toothpaste during oral 
hygiene; 
- GAgP-Triclosan group: children from GAgP parents using Triclosan toothpaste during oral hygiene; 
- GAgP-Placebo group: children from GAgP parents using placebo toothpaste during oral hygiene; 
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Each group used the respective toothpaste for 45 days. During these 45 days, they attend to 4 
visits: a baseline visit for clinical evaluation, sample collection and hygiene instruction; a 15 and 30-
days visit to reinforce the hygiene instruction, motivation and to monitor the adherence to treatment; 
and a 45-days visit to reevaluate the clinical status and sample collection. Posteriorly, all children were 
included in a wash-out period for 15 days using only the placebo toothpaste. Then, the groups were 
rearranged inverting the toothpaste they have used initially. This way, the subjects from Health-
Triclosan were reallocated in Health-Placebo, the subjects from Health-Placebo were reallocated in 
Health-Triclosan, the subjects from GAgP-Triclosan were reallocated in GAgP-Placebo, and the ones 
from GAgP-Placebo were included in GAgP-Triclosan, repeating the procedures described before for 
more 45 days.  
Clinical Evaluation 
 The clinical procedures and evaluation were performed by an experienced and calibrated 
clinician (MFM), blinded for the subgroup’s allocation. The measurements were done at baseline and 
45 days of Triclosan and placebo use, before and after the groups been crossed. The evaluated clinical 
parameters were: i) plaque index – PI [13]; ii) gingival index – GI [13]; iii) bleeding on probing – BoP 
[14]; iv)  probing depth – PD (distance between the gingival margin to the bottom of the periodontal 
pocket or sulcus); and they were measured 6 sites per tooth.  
 Microbiological evaluation 
 Saliva and subgingival biofilm were used for microbiological evaluation and were collected at 
baseline and 45 days of Triclosan/Placebo toothpaste use. Unstimulated whole saliva was collected with 
sterile Falcon tubes over 5 min and stored into Eppendorf tube, which was frozen at -20° C until the 
laboratory evaluation. The subgingival biofilm was collected with one sterile paper point per site (nº 35) 
from 2 central incisors and 2 first molar of each child and stored as a pool. The sites collected were the 
ones with the deepest PD of one molar and one incisor of the superior arcade and one molar and one 
incisor of the inferior arcade. After the supragingival biofilm removal and relative isolation with cotton 
rolls, the paper point was inserted for 30 s in the periodontal pocket/gingival sulcus. The paper points 
were stored in an Eppendorf with 300 µl of Tris-EDTA 0.5 mM and frozen at -20° C until the laboratory 
evaluation. 
The abundance of Porphyromonas gingivalis (Pg), Aggregatibacter actinomycetemcomitans 
(Aa), and Tannerella forsythia (Tf) were measured using a quantitative PCR (qPCR) technique and 
specific primers, as reported by Casarin et al [15]. The DNA was isolated from saliva and subgingival 
biofilm. A real-time PCR was performed using the FastStart DNA Master SYBR Green kit (Roche 
Diagnostics GmbH, Mannheim, Germany). The concentration of the DNA used in each run was 10 
ng/ml. The determination of the DNA genome copies in the controls was based on the genome size of 
each bacteria and the mean weight of one nucleotide pair. 
67 
 
Inflammatory evaluation 
 Gingival crevicular fluid (GCF) was collected as a pool from the same sites the subgingival 
biofilm was collected. After the subgingival biofilm was collected, the area was isolated, dried and GCF 
was collected by placing filter paper strips (Periopaper, Oraflow, Plainview, NY, USA) into the pocket 
until the clinician perceived a slight resistance, and then leaving in place for 15 s. The fluid volume was 
measured with a calibrated device (Periotron 8000, Oraflow, Plainview, NY, USA). The strips were 
placed into sterile tubes containing 100 μL of phosphate-buffered saline (PBS) with 0.05% Tween-20. 
GCF samples were immediately stored at -20 °C until multiplexed using a bead immunoassay assay.  
 Cytokine levels of interferon (IFN)-γ, interleukin (IL)-10, IL-17, IL-1β, IL-4, and tumor 
necrosis factor (TNF)-α) in GCF were determined using the Sensitivity Human Cytokine 08-plex 
(Millipore Corporation, Billerica, MA). Assays were carried out according to the manufacturer’s 
recommendations using the MAGpix™ instrument (MiraiBio, Alameda, CA). The sample’s 
concentration was estimated from the standard curve using a five-parameter polynomial equation using 
Xponent® software (Millipore, Corporation, Billerica, MA). The mean concentration of each marker 
was calculated using the individual as a statistical unit and expressed as pg/ml. 
 Statistical analysis 
 Sample size calculation was done considering alpha=5%, a power level of 80% and effect size 
of 1.0 (based on Cagetti et al [16]), a minimum population per arm was 11. In view of possible drop-
outs, 15 children were included per arm. All 30 children completed the plaque program, and all analysis 
(clinical, microbiological and inflammatory) were done with 15 patients per group (n=30), with no 
changes on the methods or on the randomization, allowing a per-protocol analysis. The Shapiro-Wilk 
test was used to analyze the data normality. For gender distribution and age, Fisher’s exact and Student’s 
t-tests were used respectively. For the clinical data analysis, non-paired (for groups comparison) and 
paired (for timepoints comparisons) tests were performed depending on the normality. Moreover, in the 
cytokine’s levels and in the bacterial concentration, due to the non-normal distribution, Mann-Whitney 
and Wilcoxon non-parametric tests were used for inter- and intra-group analysis. All tests considered 
alpha=5% and were done by a blinded statistician. 
Results 
Table 1 describes the demographic data and the baseline condition of patients divided per group. 
A similar age and gender group composition demonstrated the homogeneity of the studied population. 
Despite the same demographic characteristics, a different clinical condition could be observed in 
children from GAgP parents, with higher PI, GI, and BoP (p<0.05). Higher abundance of Aa in saliva 
and in the subgingival biofilm were observed in children from GAgP group (p<0.05). In addition, a 
reduced level of IFN-ɣ, IL-4, and IL-17 were observed in the GAgP group (p<0.05). 
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Table 1 Demographic, clinical, microbiological and inflammatory condition at baseline in children from 
Health and GAgP groups. 
 
  GAgP (n=15) Health (n=15) 
Gender (%fem) 60% 40% 
Age (years±SD) 9.2±1.7 9.0±2.0 
PI (%±SD) 36.2±14.7 & 25.1±13.1 
GI (%±SD) 10.4±4.7 & 7.5±5.3 
PD (mm±SD) 1.7±0.4 1.6±0.6 
BoP (%±SD) 25.3±7.0 & 17.9±11.4 
 A.actinomycetemcomitans  3.1±2.8 * 1.6±2.2 
Saliva 
(log10±SD) 
P. gingivalis  1.4±1.0 1.3±1.1 
 T. forsythia  1.6±1.3 2.0±1.1 
  A.actinomycetemcomitans  2.6±2.0 * 1.7±1.7 
Subgingival biofilm 
(log10±SD) 
P. gingivalis  1.1±1.7 0.3±1.1 
T. forsythia  0.1±0.5 0±0 
Gingival Crevicular Fluid 
(pg/ml±SD) 
TNF-α 6.0±4.6 13.1±22.1 
IL-10 2.3±1.4 3.4±2.0 
IL-1β 1376.4±1549.4 1458.1±1685.3 
IFN-ɣ 58.9±36.3 * 137.4±141.0 
IL-4 13.0±7.0 * 22.1±12.8 
IL-17 10.8±6.11 * 17.8±11.4 
Symbols indicate statistical difference between groups (&T -Student test and *Mann-Whitney test, p<0.05). PI – Plaque Index; 
GI – Gingival Index; PD –Probing Depth; BoP – Bleeding on probing; SD – Standard deviation; TNF - Tumor necrosis factor; 
IL – Interleukin; INF – Interferon. 
Table 2 demonstrates the effect of plaque control in all studied population, reducing the PI in 
45 days for both groups and both treatments (p<0.05). Besides plaque index reduction, Triclosan 
toothpaste demonstrated to be efficient in reducing the GI for GAgP and Health groups (p<0.05). In the 
GAgP group, the use of triclosan toothpaste additionally improved the BoP and the PD (p<0.05) after 
45 days of use.  
 
69 
 
Table 2 Clinical data of baseline and 45 days after the use of Triclosan and Placebo toothpaste per 
group.   
   PI (%±SD) GI (%±SD) PD (mm±SD) 
BoP 
(%±SD) 
GAgP 
Triclosan 
Baseline 30.8±15.8% 9.6±5.2% 1.8±0.3 26.4±11.4% 
45 days 24.7±12.0%* 7.1±4.1%* 1.5±0.4
# 22.8±8.9%* 
Placebo 
Baseline 34.1±17.0% 10.6±5.6% 1.7±0.4 24.2±12.5% 
45 days 27.7±11.1%* 10.4±8.1% 1.6±0.6 25.5±10.9% 
Health 
Triclosan 
Baseline 26.5±14.2% 8.4±5.2% 1.6±0.6 17.6±13.4% 
45 days 20.1±13.4%* 5.3±4.4%* 1.6±0.6 17.5±9.5% 
Placebo 
Baseline 26.0±12.9% 6.5±5.8% 1.6±0.6 18.6±10.2% 
45 days 22.1±11.7%* 6.6±5.3% 1.3±0.8 19.1±15.3% 
Symbols indicate statistical difference intragroup per treatment (#ANOVA two-way t-test and *Wilcoxon test, 
p<0.05). PI – Plaque Index; GI – Gingival Index; PD – Probing Depth; BoP – Bleeding on probing; SD – Standard 
deviation;  
 
 The levels of Aa, Pg, and Tf in saliva and subgingival biofilm before and after the plaque control 
is observed in figure 2. In saliva, the plaque control with Triclosan toothpaste was able to reduce 
significantly the concentration of Aa in children from GAgP parents (p<0.05), while no other difference 
was observed for the other groups and other bacteria. Regarding the bacterial concentration in the 
subgingival biofilm, the plaque control was not efficient to change the bacterial levels with any 
toothpaste in both groups (p>0.05). 
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Figure 2 Effect of plaque control using placebo and triclosan toothpaste in the bacterial concentration 
in saliva and subgingival biofilm. * demonstrate statistical differences between timepoints, Wilcoxon test 
(p<0.05).  
  
The plaque control effect in the inflammatory condition was demonstrated in figure 3. The 
placebo toothpaste use was not effective to change the cytokine concentration in the Health and GAgP 
groups (p>0.05). The Triclosan toothpaste, on the other hand, promoted a reduction on the IL-1β 
concentration in the GAgP group and a reduction in the IL-4 and IFN-ɣ in the Health group (p<0.05), 
showing an additional anti-inflammatory effect on the subgingival environment.  
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Figure 3 Effect of plaque control using placebo and triclosan toothpaste in the cytokine concentration in the 
gingival crevicular fluid. * demonstrate statistical differences between timepoints, Wilcoxon test (p<0.05). 
 
Discussion 
 The plaque control is the most wildly recommended approach to prevent periodontal disease 
and another adverse condition associated with biofilm accumulation in children and adults [7, 17]. 
However, despite benefits in the clinical condition, no study has demonstrated the benefit of plaque 
control alone on the subgingival condition of an already altered environment, as observed on the studied 
population. This study has corroborated with the previous studies [4–6] demonstrating initial alterations 
in the clinical, microbiological and inflammatory conditions in children from GAgP parents even before 
the clinical sign of periodontitis, reinforcing the idea of susceptibility factors and a risk population for 
GAgP development. That way, preventive approaches should be applied to this risk group focusing in 
monitoring and controlling their adverse periodontal conditions and the use of chemical agents 
presenting antimicrobial and anti-inflammatory properties, such as the Triclosan, should be considered 
as a treatment option. In the present study, triclosan-containing toothpaste was able to promote some 
additional benefits in clinical and host-response patterns of children from GAgP families. 
 This study has used a cross-over design to test the plaque control alone (placebo toothpaste) or 
in association with Triclosan toothpaste in controlling the clinical, microbiological and immunological 
alteration observed in children from GAgP parents. The plaque control demonstrated to be effective in 
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reducing the plaque levels for both protocols. This confirms the importance of mechanical therapy in 
controlling biofilm accumulation and its potential to reduce plaque index, as well known in the literature 
[7, 18, 19]. Moreover, the reduction in plaque index, in spite of toothpaste or familiar origin, also 
reinforce the role of the clinician in introducing, motivating and periodically reinforcing the oral hygiene 
instructions, maintaining an adequate, healthy-compatible, biofilm loading [19]. However, oral hygiene 
and placebo toothpaste were only able to reduce biofilm accumulation, and no other clinical variable 
was significantly changed over time. Triclosan toothpaste, on the other hand, demonstrated an additional 
effect in the marginal inflammation for GAgP and Health groups. In the GAgP group, the effects were 
even higher, reducing the BoP and the PD when the Triclosan toothpaste was used. Even though the PD 
and BoP alone were not enough to periodontitis diagnosis (once no clinical sign of bone loss was 
identified), these could be important signs of initial clinical alterations. The presence of higher levels of 
bleeding, edema and a proinflammatory environment could be favorable to the establishment of a more 
pathogenic subgingival condition (associated to reduced levels of  oxygen, higher levels of proteins and 
prooxidants [20–22]), favoring the colonization by Gram-negative, anaerobes and proteolytic bacteria 
[18, 20–22] and triggering the periodontal breakdown. Thus, the reduction of these parameters can 
represent an important improvement that could affect the long-term clinical condition of this population. 
These additional clinical benefits corroborate with previous studies that also showed the potential of this 
molecule in promoted good clinical benefits in adults and children [8, 9, 23–25]. All these benefits are 
attributed to its antimicrobial and anti-inflammatory properties of Triclosan. 
 Triclosan is a broad-spectrum antibacterial agent, that acting in the bacterial cytoplasmic 
membrane can achieve a bacteriostatic or bactericidal action depending on the dose [8]. Its action on 
bacterial growth and the influence on key bacterial metabolic pathways, in both Gram-positive and 
Gram-negative bacteria, is supposed to modulate the bacterial load in the biofilm [9]. This antimicrobial 
activity was seen in the present study once only triclosan usage was able to reduce some bacterial 
content. Triclosan toothpaste promoted a reduction of Aa in saliva in children from GAgP parents, a 
situation that was not observed with the use of placebo toothpaste neither in children from healthy 
parents. However, no effect was observed in the subgingival biofilm, suggesting a reduced effect of 
Triclosan antimicrobial properties subgingivally. That condition could be explained by the reduced 
access of this chemical agent in the subgingival environment and/or by the reduced ability of 
antimicrobials to act in an organized and established biofilm [26, 27]. The effect of Triclosan toothpaste 
in reducing Aa concentration has been demonstrated in experimental gingivitis studies and in the 
maintenance of dental implants [11, 28], however, these studies evaluated its influence on the biofilm 
formation and on a supragingival biofilm. When the subgingival biofilm was considered, a 5 years study 
evaluating the effect of Triclosan toothpaste in the subgingival microbial composition and periodontitis 
progression in cardiovascular patients was not able to demonstrate additional benefits of this 
antimicrobial to change the microbial composition even slowing down the periodontitis progression 
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[29], suggesting a small effect of this agent on the subgingival microbiota. Another important aspect is 
that GAgP children presented higher levels of Aa at baseline. The presence of Aa subgingivally has been 
associated with the risk of periodontal disease, precocious bone loss and clinical attachment loss in 
adolescents [30–33]. Thus, the higher levels of Aa in children from GAgP parents can represent a risk 
and its reduction should be an important metric to be evaluated and monitored, especially in this risk 
population. Thus, the reduction of Aa levels after the therapy would be a desirable effect when 
considering the periodontitis prevention and disease control, and future studies should identify a therapy 
that also promotes alterations in the subgingival pathogens. Anyway, despite this slight antimicrobial 
effect noted only in GAgP children, Triclosan therapy exhibited a more pronounced reduction in 
bleeding levels. This phenomenon could be attributed to another important characteristic of this 
molecule – its anti-inflammatory potential.   
 Regarding the anti-inflammatory properties, in vitro studies have shown the efficiency of 
triclosan in modulating the inflammatory response. It was demonstrated the Triclosan potential to reduce 
the production of prostaglandin E2 (PGE2), a potent stimulator of bone resorption and inflammatory 
events, by modulating the IL-1β and TNF-α actions [34, 35]. Furthermore, it was indicated that triclosan 
inhibits human fibroblastic cells to produce and secrete IFN-ɣ after stimulation[36], and inhibit oral 
epithelial cell to produce LPS-induced pro-inflammatory responses by inducing miRNA regulation of 
the TLR-signaling pathway [37], modulating that way the tissue destruction. In the present study, 
placebo toothpaste has not altered the cytokine levels in the gingival crevicular fluid in both groups, 
despite the reduction on the plaque levels. On the other hand, the Triclosan toothpaste has reduced the 
levels of IL-1β in the GAgP group and the levels of IL-4 and IFN-ɣ in the Health group. IL-1β is a pro-
inflammatory cytokine and its higher concentration on the GCF have been associated with periodontal 
disease and clinical attachment loss[38]. In this context, some studies have demonstrated the ability of 
Triclosan to modulate IL-1β during the microbial challenge. Skold-Larsson et al [34] have reported the 
effect of Triclosan in reducing the IL-1β levels in orthodontic patients and Ribeiro et al [10] demonstrate 
that triclosan was able to modulate the increasing of this cytokine during experimental mucositis. In 
vitro study also demonstrated the downregulation of IL-1 after LPS stimulation in leukocytes cells 
treated with Triclosan [12]. Regarding IFN and IL-4, Barros et al, demonstrate the efficiency of 
Triclosan to regulate the expression of IFN molecules and suggest that triclosan can inhibit the acute 
inflammatory response and may also inhibit the transition from an acute to chronic inflammatory state 
[12]. Furthermore, IL-4 is reported to be an important anti-inflammatory cytokine that modulates the 
osteoclastogenesis [39] and its reduction concomitantly to IFN-ɣ (a proinflammatory cytokine) 
reduction can be associated with the decrease of clinical inflammatory levels promoted by brushing with 
Triclosan toothpaste (as demonstrated by the reduction of GI) and the achievement of a more equilibrate 
host-response. Interestingly, Triclosan differently acted in each population, by altering different 
cytokines in GAgP and Health groups. This reinforces the intrinsic and unique characteristics of 
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aggressive periodontitis and future studies might investigate which cell mechanisms and inflammatory 
pathways were affected in each condition. 
 In summary, the plaque control without the use of an antimicrobial and anti-inflammatory agent 
reduced the plaque accumulation levels, although, no other change on the clinical parameters, 
microbiological or inflammatory composition was demonstrated. On the other hand, the Triclosan 
toothpaste leads to a broader effect by controlling the inflammatory clinical indexes and cytokines, 
probably a result of its anti-inflammatory properties, and especially in the GAgP group also reducing 
the BoP and salivary level of Aa that were altered at baseline. These results highlighted the beneficial 
aspect of the use of chemical agents in association with plaque control, especially in a risk population 
with precocious alterations, focusing in control the adverse condition that can trigger the periodontal 
breakdown, preventing periodontal disease. Meanwhile, Triclosan toothpaste demonstrates to a be an 
interesting option by controlling the inflammatory parameters at the same time that presents an easy 
application, secure, and it does not change the children’s oral hygiene routine. However, due to no effect 
on the subgingival levels of pathogens, more studies should be stimulated focusing in control the 
subgingival microbial condition of this population. In addition, this study has analyzed a short-term 
period of Triclosan uses (45 days) and more investigations should be conducted to evaluate if long-term 
use of this chemical agent would be able to improve the periodontal condition achieved on this study, 
especially for a high-risk population as the GAgP descendants. 
 This research has analyzed a reduced number of bacterial species and cytokines, what does not 
allow a comprehensive evaluation of the biofilm, the inflammatory condition and the identification of 
risk markers to that population. However, despite the limitations of this study, it reinforces that children 
from GAgP parents are a risk group to development of periodontal disease and that the oral alterations 
occur in early ages, even before any clinical sign of bone loss and disease diagnoses. Furthermore, it 
was shown that the plaque control with a placebo toothpaste reduces the plaque accumulation, but it is 
not enough to control the microbiological and inflammatory alterations, probably because they are not 
a result of plaque accumulation alone but associated to the familial influence on the children periodontal 
condition, on the inflammatory response pattern and on the colonization factors [5, 40, 41]. Thus, more 
efficient and specific approaches should be recommended to that risk population, focusing on preventing 
or controlling the establishment of more pathogenic conditions, and the triclosan toothpaste can be one 
alternative to this purpose.  
 
Conclusion 
 In conclusion, the triclosan toothpaste demonstrated to be more efficient than placebo toothpaste 
to control the periodontal condition in children from GAgP parents, by reducing the BoP, PD, salivary 
Aa, and IL-1β levels. 
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3 DISCUSSION 
 The familial aggregation of GAgP is widely described in the literature (Michalowicz et 
al., 2000; Nibali et al., 2008; Meng et al., 2011) and its occurrence is attributed to the 
transmission of some specific risk factors, such as genetic, microbiological, behavioral and 
environmental from one affected subject to their offspring (Haubek, 2010). This way, the 
comprehension of these risk aspects will facilitate the understanding of the pathological aspects 
and susceptibility to periodontal disease (still not fully understood (Könönen and Müller, 2014; 
Vieira and Albandar, 2014)), besides to orient the implementation of preventive approaches to 
that risk population. These were the motivation of the present research, focusing both in the 
characterization of the subgingival environment of that population and in the management of 
the precocious alterations. 
 The presented studies used the periodontal disease classification of the American 
Academy of Periodontology, 1999 (Armitage, 1999) as the parameter for patient selection, once 
they started in 2014 and 2016. However, a new classification was emerged in 2018 (Caton et 
al., 2018) and the GAgP was extinct as a specific disease, been classified as periodontitis grade 
C, characterized by the rapid rate of progression. The new classification does not mention the 
familial aggregation as an important feature, but it offered the opportunity for the inclusion of 
other risk aspects that alters the disease pathogenic course.  Despite the extinction of the 
nomenclature, the evidence that correlated the severe cases of periodontitis with rapid 
progression to the accumulation of cases in the same family were vast (Michalowicz et al., 
2000; Nibali et al., 2008; Meng et al., 2011; Vieira and Albandar, 2014), justifying the 
investigation of this aspect in rapidly progressive cases and the possible inclusion of this criteria 
as a risk factor to disease occurrence.  
 The first study used of comprehensive analysis to demonstrate the effect of the familial 
component in the periodontal disease and to identify possible risk factors associated with a 
periodontal breakdown. The bioinformatics analysis revealed a strong influence of parents’ 
periodontal status in the periodontal condition of their children, both in the subgingival 
microbiome and in the host response to its aggression, and the existence of some specific 
pathogenic characteristics since childhood can be one of the explanations to the higher 
susceptibility of GAgP descendants to also develop GAgP. The higher similarity within family 
member just reinforces the use of the family study designs to investigate the cause of such 
resemblance and to search for risk factors and biomarkers.  
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 A dysbiotic microbiota was described in children from GAgP parents, with higher 
abundance of gram-negative and anaerobic bacteria than demonstrated in children from healthy 
parents. Furthermore, species and genera such as Filifactor alocis, S. parasanguinis, F. 
nucleatum, T.forsythia, P.gingivalis, and Selenomonas, usually associated to periodontal 
disease and GAgP (Faveri et al., 2008; Fine et al., 2013) were highly prevalent in the risk 
population, suggesting a structural and functional importance of this bacteria to the composition 
of the pathogenic environment related to the disease. The host response to this dysbiotic 
microbiome was also altered, as demonstrated by the more intense correlations between species 
and cytokines, suggesting an unbalance between the body defense and the microbial 
aggressions. Nowadays, this unbalances and the break of the homeostasis is considered the 
cause of periodontitis (Lamont et al., 2018). Altogether, point to a risk for children from the 
GAgP parent, in a long-term, to develop the disease, a situation that will only be confirmed by 
longitudinal studies.  
 The similarity between parents-children microbiome suggests the vertical transmission 
and the precocious colonization for pathogenic bacteria as an important aspect of dysbiosis 
establishment and disease occurrence. However, other factors should also be interfering on this 
situation, such as susceptibility to colonization and an altered host response that creates the 
environmental conditions for the establishment of the dysbiotic microbiota (Lamont et al., 
2018). Nibali et al, for example, described how the polymorphism in the IL-6 gene was 
correlated to a higher colonization for A. actinomycetencomitans (Nibali et al., 2007; Nibali et 
al., 2012) and they suggested the study of the infectogenomics (Nibali et al., 2009) (how the 
genetic background can determine the dysbiosis/the colonization for some microorganisms). 
Thus, other facts should be investigated to understand fully the susceptibility to periodontal 
disease.  
 Once the precocious alterations were identified and a higher risk was suggested, 
alternatives to prevent/control these changes should be proposed, in order to avoid the early 
colonization by a pathogenic microbiome and the disease initiation. The plaque control is the 
most used preventive approach to prevent periodontal disease since the biofilm accumulation 
is related to disease etiology (Kinane et al., 2017). Furthermore, the experimental gingivitis 
studies have demonstrated the effectiveness of plaque removal to control the clinical 
inflammation (Löe et al., 1965; Trombelli et al., 2004) and that way reducing the risk of 
periodontal loss in a long-term (Lang et al., 2009). In the present study, despite the beneficial 
clinical results obtained by the plaque control, this therapy was not enough to modulate the 
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pathogenic microbial profile identified in GAgP parents’ descendants. In contrast, the plaque 
removal increased the differences between children from GAgP and Health parents, evidencing 
the higher pathogenicity of the subgingival environment of GAgP group by demonstrating that 
most of the pathobionts correlated with periodontitis (such as A. actinomycetemcomitans, 
Filifactor alocis, Streptococcus parasanguinis, Porphyromonas gingivalis, Treponema 
denticola, Fusobacterium nucleatum, Tannerella forsythia) were increased and higher 
prevalent in that microbiome. Additionally, the strong resilience observed in the GAgP 
microbiome was an interesting finding of this study once it could guide the interventions for 
that population. The resilience, the capacity of the microbiome to return to the initial condition 
after catastrophic intervention (Sommer et al., 2017), of this dysbiotic microbiome, 
demonstrated that profound intervention that exceeds the adaptative capacity of the community 
should be proposed to reestablish a health-associated condition. Thus, the use of other 
approaches in addition to plaque control, such as antimicrobial and anti-inflammatory agents 
or probiotic modulation, should be tested as options for clinical management of that risk 
population.  
 In this context, our groups tested the Triclosan-containing toothpaste as a therapeutic 
alternative to control the pathogenic subgingival profile in children from GAgP parent once this 
product presents important antimicrobial and anti-inflammatory properties and its clinical 
efficacy in reducing plaque an inflammation was largely described in the literature (Barros et 
al., 2010; Pancer et al., 2016; Ribeiro et al., 2018). Besides the chemical properties of triclosan, 
the triclosan-containing toothpaste is commercially available, safe, it is accessible to the 
population and its application does not cause an impact on the daily oral hygiene routine, 
favoring the self-application, the clinical management and increasing the children’ compliance 
to the proposed treatment. The study confirmed the low effectiveness of the plaque control 
alone to modify the different periodontal pattern described in this research. The only effect of 
plaque control alone was in the plaque index, confirming the necessity to use an adjunctive 
approach in association to plaque control. On the other hand, the Triclosan toothpaste 
demonstrated an interesting additional effect on the clinical indexes and in the cytokine 
markers, demonstrating, somehow, the modulation of the inflammatory response against to the 
subgingival aggressions. In contrast, an expected microbiological effect was not demonstrated 
for triclosan, that failed to reduce the analyzed microorganisms. Thus, the evaluation of other 
methods to control the precocious subgingival changes is still desirable, focusing in identify 
effective methods to control the risk aspects in the susceptible population.  
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 In summary, the research line demonstrated that the study of families is an important 
tool to understand the periodontal disease pathogenesis, as well as to understand risk and 
susceptibility in descendants of diseased subjects. Thus, more studies should be designed using 
the familial aggregation concept, aiming the comprehension of the long-term consequences of 
the described alterations and the role of the host factor (such as genetic and host response) in 
the pathogenic process and in susceptibility. Furthermore, these studies can guide the clinical 
practices by highlight the importance of the clinical management in descendants of subjects 
with periodontal disease, that should be included in efficient preventive programs and should 
be monitored periodically to allow the precocious diagnose and early treatment. Finally, the 
discoveries of these researches break clinical paradigms by demonstrating that the plaque 
control alone, the most used preventive approach to prevent periodontal disease and broadly 
recommended for periodontists and pediatric dentist, is not efficient to control the alterations 
in this risk population and more efficient approaches should be the focus of future studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
84 
 
4 CONCLUSIONS 
In conclusion, the microbiome, as such as their relationship to the host immune system, 
is altered in subjects affected by GAgP and their descendants, what may be related to with 
periodontitis pathogenesis and susceptibility to disease. Furthermore, a strong relationship 
between the parent and their children periodontal condition was demonstrated and the sharing 
of that characteristics can be related to the familial aggregation of severe cases of periodontitis.  
Additionally, besides the dysbiotic microbiome and the more pathogenic subgingival 
environment identified in GAgP descendants, children from periodontitis-affected parents 
presented a strong resilience to subgingival microbial shifting after plaque control, highlighting 
the higher risk for disease development and the low effectiveness of plaque control to control 
this risk.  
Regarding the preventive approach, the plaque control with triclosan dentifrice 
demonstrated to be more efficient than plaque control with placebo toothpaste in controlling 
the more pathogenic profile of GAgP descendants, by reducing the BoP, PPD, salivary Aa and 
IL-1β, in children from GAgP parents. 
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